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Abstract
Haplotype-based association studies offer an exciting potential methodology for the
identification of genes that contribute to complex traits. There is thus great interest in
understanding the biological forces that shape haplotypes. We have studied a well-
characterized genetic locus surrounding the gene responsible for hereditary
hemochromatosis (HFE) to investigate the impact of meiotic recombination events upon
haplotype structure in this region. First we identified crossover hotspots in order to
define the boundaries of haplotype blocks in this locus. We then found that gene
conversion events play a significant role in shaping haplotype structure within these
haplotype blocks. These gene conversion events were not limited to recombination
hotspots and occurred with a frequency as high as 1 in 10 4 per site per generation. Gene
conversions lead to the creation of new haplotypes and we suggest that they are important
for the spread of disease alleles in a population. In addition, we discuss how these events
can be used as important tools in haplotype-based association studies.
We also present an association study in a large Venezuelan cohort to search for genes that
contribute to residual age of onset in Huntington's disease. We demonstrate significant
association between multiple alleles in a region on chromosome 6p21.3. We identify two
candidate genes in this region, HFE and histone Hlt and demonstrate significant
association of this region with age of onset in a male-specific model.
Thesis supervisor: David E. Housman
Title: Ludwig Professor of Biology
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make our research at MITpossible.
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Chapter 1
Introduction
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Complex traits, Association studies, and the International HapMap Project
Complex traits, including diabetes, schizophrenia, and cardiovascular disease, are
traits that do not segregate in a clear Mendelian fashion. There is currently great interest
in finding genes responsible for contributing to complex traits. These traits are
considered complex because more than one gene contributes to overall phenotype, and
there is often interaction between these genes as well as interactions between the genes
and the environment.
One strategy for finding the genes that contribute to complex traits is based on
linkage analyses. This approach has proven to be highly successful for finding genes that
are inherited in a Mendelian fashion in which a single gene contributes to a single
phenotype. For Mendelian traits, this approach carries with it a systematic certainty that
there is a single site within the genome with a variant sequence responsible for the
disorder. As additional family members are added to the study, the candidate interval
within which the variant sequence is known to lie becomes progressively narrowed. The
success of this approach for Mendelian disorders has led to interest in applying this
strategy for complex trait analysis; however, studies based on linkage alone have
significant limitations. While the localization of a relevant gene can be achieved through
linkage analysis, our ability to define a candidate interval is usually restricted to a large
genetic region of 20 cM or more since each gene has only a partial contribution to overall
phenotype. Major increases in study size do not effectively reduce this interval.
Association studies offer a promising alternative or adjunct to linkage for the
discovery of genes that contribute to complex traits. These studies compare populations,
not families, to find alleles that are shared among an affected group and not among an
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unaffected control group. Association studies, in effect utilize the same basic approach
that genetic linkage studies use in families to narrow the candidate interval around an
allele that contributes to the disease phenotype. In Figure 1, we have attempted to
illustrate the commonality between these approaches.
Linkage analyses are performed in families in which a single disease-causing
allele is passed through several generations in the family. This type of analysis relies on
the identification of crossover events which surround the gene containing the disease-
causing mutation and which are occur over two or more generations in the family. In
Figure a we can trace the transmission of a disease gene from a parent who is shown
affected by a clinical phenotype (disease) inherited in an autosomal dominant Mendelian
pattern with full penetrance. One of this parent's chromosomes (red) carries a mutation
(indicated by the star) that causes his disease. During meiosis, this parent's
chromosomes will undergo crossing over such that each of his children will receive some
combination of his red and green chromosomes. The children receiving the red portion
carrying the disease-causing variant will be affected. As more related individuals are
collected, the interval containing the disease-causing allele narrows further and further.
Finally, it may become possible to identify a single candidate region such as a
transcription unit, within the interval.
The power of association studies for locating the gene of importance in causing a
clinical phenotype in a particular chromosomal interval is based on analogous logic.
Figure b illustrates this concept. In the association study, the individuals under study
are treated as though they are members of an extended family based on the concept that a
single ancestral mutation is assumed to be responsible for the disease phenotype in many
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of the affected individuals in the study. Despite the absence of the many individuals who
represent the family members who connect these individuals, the goal is to identify
chromosomal regions which are identical by descent (i.e. derived from a common
ancestor) among a significant number of affected individuals compared to control
populations. Thus, in Figure b, the red chromosome with the disease-causing mutation
is now representative of a common ancestral chromosome. After many generations and
crossover events, descendents of this initial ancestor will carry smaller and smaller shared
(red) chromosomal segments. Individuals who receive the portion of the red
chromosome carrying the disease-causing variant will carry that particular genetic
contribution to phenotype.
Association studies thus take advantage of markers that are inherited together
with, or said to be in linkage disequilibrium (LD) with a disease causing allele. These
markers are inherited together more frequently than expected by chance, thus disobeying
Mendel's law of independent assortment. In Figure lb, these markers would lie on the
red portion of the chromosome that is inherited together with the disease-causing variant.
Meiotic crossover events create the boundaries of these stretches of LD, and an important
foundation to the success of association studies lies in the patterns of crossover
recombinations that occur in the genome. These crossover events are known to occur not
randomly, but limited to punctate regions called recombination hotspots (RHS) (Daly et
al., 2001). The molecular characteristics of specific RHS have been described by sperm
typing analyses using markers flanking the sites of crossing over (Jeffreys et al., 2001;
Jeffreys et al., 2000). RHS flank LD blocks, which themselves, by comparison, are
thought to be relatively cold regions for recombination (Daly et al., 2001) . Each stretch
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of LD can also be described by the specific set of alleles inherited together there, known
as a haplotype block. Human populations share common haplotype blocks, stemming
from shared ancestry, and each block can usually be described by only a few distinct
haplotypes (2-5) in any given population (Patil et al., 2001). Haplotype block lengths are
thought to reflect population history: older African haplotypes which have had more
chances for recombination events tend to be shorter, while younger, European
populations tend to have longer haplotype blocks for example (Reich 2001).
Another critical component of association studies is the availability of appropriate
markers. One of the consequences of the human genome sequencing project was the
immediate identification of over 1.4 million single nucleotide polymorphisms, or SNPs,
which serve as excellent candidate markers for association studies (Sachidanandam et al.,
2001). SNPs are ancient sites of variation that are present on the level of single DNA
bases and make up the majority of variations present between any two individuals
(Shastry, 2002). SNPs have a low mutation rate and are found frequently throughout the
genome (about 1 SNP per kb in both exonic and intronic regions) (Cargill et al., 1999;
Shastry, 2002). The National Center for Biotechnology Information (NCBI) has a public
database called "dbSNP" that contains SNP information that serves as a freely accessible
resource for the scientific community (http://www.ncbi.nlm.nih.gov). By 2003, this
database already contained 5.7 million SNPs with unique positions in the genome
(Consortium, 2003).
One approach to association studies that holds great promise is to look for
haplotypes defined by SNP markers that are enriched in a disease-carrying population
and not in an unaffected group (Cardon and Abecasis, 2003). Comparing blocks of
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haplotype, rather than entire genome-wide sequence, reduces the complexity of
comparing two populations (in this case disease vs. non-disease). The rationale is that
markers on these shared haplotype blocks, if not themselves the causal mutations, will be
in LD with the causal variant. This strategy was used to uncover a "risk haplotype"
enriched in a population with Crohn's disease, one of two common types of inflammatory
bowel diseases (Rioux et al., 2001).
The International HapMap Project, commonly known as the "sequel" to the
Human Genome Project, was designed to provide a resource of information about SNP
genotypes, frequencies, and measurements of LD across the genome (Consortium, 2003).
Phase I of the project released over 1 million SNPs genotyped in 269 individuals with
African, Asian, and European descent (30 trios-2 parents and child from Utah population
in United States, 30 trios from Yoruba people in Ibadan, Nigeria, 45 unrelated individuals
from the Han Chinese in Beijing, China, and 44 unrelated Japanese people from Tokyo,
Japan) (Altshuler et al., 2005). Phase II of the project will include an additional 4.6
million SNPs. "Common" SNPs, with minor allele frequencies of greater than 5% were
specifically selected for this project. An additional 10 regions of the genome each 500 kb
in length were sequenced in 48 individuals to discover both common as well as rare
SNPs. These SNPs were then genotyped in the entire panel of 269 individuals. The
block-like structure of LD across the genome as well as the limited haplotype diversity
inferred from smaller studies was confirmed by analyses of initial HapMap data releases
(Altshuler et al., 2005).
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Recombination events that shape haplotypes: crossovers and gene conversions
The exciting potential of haplotype-based association studies for the discovery of
disease genes contributing to complex traits makes the understanding of biological
mechanisms that shape haplotypes of great interest to the scientific community. There
are still many gaps, however, in our understanding of the nature of these forces and their
impact on haplotype structure. The two major biological mechanisms known to shape
haplotypes are mutation and recombination. Mutations can change a given haplotype
block by altering a single nucleotide or a stretch of sequence. The impact of this
mechanism on haplotype is closely related to the rate at which such an event can occur.
Hotspots for mutation, known as CpG dinucleotides, have extremely high mutation rates.
The CpG single base mutation in the FGFR3 gene, for example, associated with
achrondroplasia (a dominantly-inherited condition with short stature), has one of the
highest recorded mutation rates of about 1 x 10-5 per generation (Crow, 2000). Mutations
at non-CpG sites, however, estimated by comparing pseudogene sequence divergence
between chimpanzees and humans, occurs much less frequently, on the order of 1-2.7 x
1 08 per nucleotide per generation (Nachman and Crowell, 2000).
The second important force governing haplotype structure is meiotic
recombination. Meiotic recombination, the exchange of genetic material between
homologous chromosomes (homologs), ensures the maintenance of diversity from
generation to generation. Although the term "recombination" is commonly used to refer
specifically to crossover events alone, it is more classically defined to encompass both
crossover events as well as gene conversion events. While these two processes can both
arise during a meiotic event, their products are distinctly different. Crossover events
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result in the reciprocal exchange of chromosomal segments between homologs, while
gene conversion events result in the non-reciprocal exchange of genetic material that can
arise after heteroduplex formation and mismatch repair of a single homolog. Much of
our understanding of meiotic recombination events derives from studies in yeast in which
all four products of a single meiotic event can be recovered. Recent advances in SNP
resequencing and sperm typing (Arnheim et al., 2003; Carrington and Cullen, 2004;
Kauppi et al., 2004), have improved our ability to study these events in mammalian
systems.
Meiotic crossover events, as mentioned earlier, take place at RHS and result in the
formation of haplotype block boundaries. Crossovers occur once per chromosome or
once per chromosome arm per generation and are thought to be essential for the
successful completion of meiosis. Studies in yeast indicate that crossovers are initiated
by double strand breaks catalyzed by the enzyme Spo 1 (Lichten and Goldman, 1995).
While definitive shared sequence motifs driving RHS have not been identified, several
observations have been made in yeast regarding RHS location. Correlation has been
seen, for example, with sites of transcription factor binding (referred to as ca-hotspots),
sites of nuclease sensitivity (-hotspots), and GC-rich region (y-hotspots). These are all
thought to be associated with the modification of histones that leads to the availability of
the chromosome to the recombination machinery (Petes, 2001).
In mammals, RHS are determined in several ways. First, they can be inferred by
the local breakdown of LD between markers. This can be performed as haplotype
analysis over a set of markers demonstrating the location of block boundaries and the
"swapping" of chromosomal segments between haplotypes. This methodology is useful
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in showing where historical crossovers have taken place. RHS can also be inferred by
pairwise measurements of LD. The most commonly used description of LD between two
markers is D'. If two loci, A and B have alleles A,a and B,b with frequency (p), then
pAB=pA*pB if complete linkage equilibrium (independent assortment) is observed. Any
deviation from this is measured by a value D, where D=pAB*pab-pAb*paB. This
measurement of LD, however, depends highly on allele frequencies, so the measurement
D' is used more frequently, in which D'=(pAB-pApB)/Dmax, where Dmax equals the
maximum absolute value of the numerator (Strachan and Read, 2004). D' measurements
are limited by the fact that they are limited to pairwise comparisons between markers.
This method also shows evidence for historical sites of crossover recombination between
blocks of conserved LD (Gabriel et al., 2002).
To observe RHS over a single generation, pedigree mapping, in which crossovers
can be identified using parental information, can be used. Only limited information can
be provided by such analyses, however, given the low frequency with which crossovers
occur over each generation. Another more robust method is to directly observe crossover
events in single sperm, called sperm typing. Using allele specific PCR in single sperm,
Jeffreys et. al. characterized several hotspots in the MHC II region of chromosome 6
(Jeffreys et al., 2001; Jeffreys et al., 2000). These studies reported hotspots of 1-2 kb in
width, at sites where RHS were previously identified using pedigree recombination
mapping. In addition, the hotspots identified by sperm typing were also shown to
correlate with the location of hotspots that could be identified using LD breakdown
measured by the D' statistic. Most crossovers were simple, with only a few showing
evidence of accompanying gene conversions. Interestingly, hotspots were also reported
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in clusters of 2-3 sites of elevated recombination that were each separated by 1-7 kb
(Jeffreys et al., 2001).
More recently, coalescent models have also been developed to estimate RHS from
population-wide variation data. Coalescent methods use currently existing polymorphism
information to derive inferences about most recent common ancestry. McVean et. al.
used a coalescent-based method to identify RHS and showed that this method could
predictably localize RHS in regions where hotspots were previously identified by fine-
scale sperm mapping or pedigree mapping (McVean et al., 2004). This group applied
this methodology to predicting RHS and recombination rates across the genome using
HapMap data (Myers et al., 2005). They report over 25000 RHS occurring on average
about once every 50 kb. While they did not find any single sequence motifs common to
all hotspots, several sequences were enriched in hotspots more than others. Among these,
was the short motif (CCTCCT) that was found associated with hotspots when in the
context of two retrovirus-like retrotransposons: THE A and THE 1B (Myers et al., 2005).
Another important product of meiotic recombination is gene conversion events
that results in the unidirectional transfer of genetic information. These recombination
events are becoming recognized as important factors in fine-scale haplotype evolution.
While crossover events produce the boundaries of haplotype blocks, gene conversion
events result in the decay of LD between markers within a block over a short distance.
The importance of this mechanism in fine-scale haplotype mapping has emerged from
studies that model LD decay which demonstrate that crossover events alone are
insufficient to explain the lack of LD that is often observed between markers that are
otherwise expected to be tightly linked. Inclusion of gene conversion into these models
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allows for a better fit with existing LD data suggesting the important role of gene
conversion events in shaping haplotype (Ardlie et al., 2001; Frisse et al., 2001).
Padhukasahasram, et. al. (2004) modeled fine-scale LD using markers along chromosome
21 and proposed that gene conversion events occur at a ratio of 1.6-9.4 times the
frequency of crossover events (Padhukasahasram et al., 2004).
Our molecular understanding of gene conversions derives largely from studies in
yeast. In yeast, gene conversions can accompany two major products of recombination
called crossover products and noncrossover products. While both of these pathways
follow a double strand break, only the crossover pathway gives rise to chromosomes with
reciprocal exchange. The mechanisms that produce crossover and noncrossover products
were once thought to derive from the relative resolution of a single intermediate
containing two junctions known as Holliday junctions (Szostak et al., 1983). Recently,
however Borner, et. al. (2004) showed evidence supporting an "Early Crossover
Decision" model, in which the decision between these two pathways is made early in
prophase, before the formation of a stable common intermediate can be observed (Bishop
and Zickler, 2004; Borner et al., 2004). By extrapolation, this model gives rise to the
possibility that gene conversion events associated with noncrossover products are not
limited to regions where crossover events take place.
In mammals, many observations of intra-allelic gene conversions have been
reported especially for duplicated regions of the genome. Studies of interallelic meiotic
gene conversions have also recently emerged. Single sperm analysis has been used to
examine these events at sites of crossover hotspots. In the mouse, several groups have
looked at gene conversion events occurring at previously established RHS where
17
crossovers were also known to occur (Guillon and de Massy, 2002; Yauk et al., 2003).
Guillon and de Massy (2002) examined a RHS in the Proteosome subunit b type 9
(Psmb9) locus and reported 16 gene conversions in 6000 molecules of sperm DNA, with
conversion tract lengths of less than 540 bp. In humans, Jeffreys and May (2004)
similarly examined three loci with previously defined crossover hotspots. Using single
sperm typing, they found gene conversion events in each of these hotspots with mean
tract lengths ranging from 55-290 bp. They reported gene conversion: crossover
frequency ratios ranging from 4:1 to 15:1. They also demonstrated that within each
hotspot a gradient of recombination activity could be observed, in which the location of
peak crossover activity corresponded with the location of peak gene conversion activity
(Jeffreys and May, 2004). However, they do not address the possibility of conversion
events outside of these defined crossover hotspots.
The HFE region and this present work
In the present work, we address the limitations in our understanding of the impact
of recombination on haplotype structure by investigating the behavior of haplotypes in a
region where disease-causing mutations are already characterized. The objective was to
study haplotypes in a region where mutations were already known to gain insight that
could impact future association studies in the search for genes whose role in disease are
not yet known. The hemochromatosis (HFE) gene, associated with autosomal recessive
hemochromatosis Type 1 in humans, was an ideal candidate region for this study.
Hereditary hemochromatosis is a disease of iron overload common to individuals of
Northern European decent. Phlebotomy can successfully reduce iron overload, but if left
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untreated, clinical sequelae can include serious complications such as liver cirrhosis,
diabetes, and heart failure. The HFE gene, located on chromosome 6p21.3, is an HLA
Class I-like gene, with two major mutations that can lead to hemochromatosis: C282Y (G
to A transition at nucleotide 845), and H63D (C to G transversion at nucleotide 187)
(Feder et al., 996). C282Y is thought to interfere with the ability of HFE to reach the
cell surface where it can regulate the interaction between the transferrin receptor with
transferrin (Feder et al., 1998; Feder et al., 1997). While 80-90% of patients who present
with clinical symptoms of hemochromatosis in Northern Europe are C282Y
homozygotes. the clinical penetrance is not complete (Feder et al., 1996; Waalen et al.,
2002). The significance of the H63D mutation is also complex and is thought to be most
clinically significant when found in a compound heterozygote accompanying a C282Y
mutation. The prevalence of these mutations is very high in individuals with European
ancestry (Merryweather-Clarke et al., 1997). 1 in 8 individuals in Northern Europe carry
the C282Y mutation and 1 in 200 are homozygotes, while 25% of individuals throughout
Europe are thought to carry the H63D allele (Distante et al., 2004). A third mutation,
S65C, is present in 3% of individuals from Northern Europe (Distante et al., 2004). Like
H63D, S65C is thought to become clinically significant when associated with a C282Y
mutation although again with incomplete penetrance. The C282Y mutation lies on an
extended haplotype suggesting a relatively recent origin. The HLA A3/B7 alleles have
long been associated with C282Y, and with the exception of a report from a population in
Sri Lanka (Rochette et al., 1999), this mutation is thought to have only a single origin.
H63D, on the other hand, lies on a haplotype extending only about 700 kb. There have
been several reports placing H63D on unique haplotypes, including an investigation that
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placed it on 3 unique haplotypes defined by three polymorphisms spanning 10.6 kb in the
HFE gene (Rochette et al., 1999).
Although defined by a Mendelian recessive inheritance pattern, the penetrance of
the HFE mutations and the fact that more than one mutation can interact to produce a
phenotype make the HFE locus an ideal candidate for a study to address issues that will
impact future association studies to find genes involved with complex traits.
We demonstrate the location of a local cluster of recombination hotspot activity in
the HFE gene using haplotype analysis in the immediate region surrounding the HFE
mutations. We also report gene conversions in the human locus using C282Y
homozygotes and present the first direct evidence for gene conversions arising from
female meiosis in the mouse. Based on the high frequency with which we observe
conversion events and our analysis of H63D haplotypes, we also suggest that gene
conversion may have been a mechanism which led to the spread of this disease allele. As
an additional study we also present an association analysis to investigate the impact of
alleles in the IIFE locus on age of onset in a large Huntington's disease cohort. We show
that a specific haplotype exists in the population containing alleles that lead to a later age
of onset of the disease.
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Figure 1: Schematic to illustrate the basic concepts underlying linkage and
association studies for the discovery of a disease-causing mutation.
a: Linkage analyses
Linkage analyses are performed in families. A hypothetical parent affected by a disease
passes on a disease-causing allele (star) to each of his children receiving the portion of
his red chromosome containing the mutation. Over generations, each successive
crossover recombination event narrows the interval further.
b: Association studies
Association studies are performed in populations, not families, but use a similar logic.
Here, the red chromosome with the disease-causing mutation represents an ancestral
chromosome. Each descendent who receives the portion of the red chromosome with the
mutation will be affected by the disease. Many generations will result in many crossover
recombination events that lead to smaller and smaller shared segments from the red
chromosome.
Figure 1
a
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b
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Chapter 2
Haplotype analysis of recombination events in the HFE locus
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ABSTRACT
Haplotype structure in human populations is influenced by three biological
processes: de novo mutation, crossing over, and gene conversion. In order to gain a
better understanding of the relative contributions of these processes to haplotype
evolution at a specific locus in the human genome, we have chosen to analyze the human
hemochromatosis locus (HFE). Using panels of chromosomes from different
populations, we have identified sites of increased crossing over within this region.
One relatively recent mutation in the HFE gene, C282Y, has allowed us to identify
chromosomes with a shared common ancestry. By comparing chromosomes marked by
the C282Y mutation, we identified a site of gene conversion which is not found within a
recombination hotspot. We have also assessed haplotype structure around the more
widespread H63D mutation, which suggests that gene conversion was a likely mechanism
for the movement of the H63D mutation onto different haplotype backgrounds.
The presence of gene conversions in human chromosomes outside of
recombination hotspots led us to systematically search for gene conversion events in real
experimental time. We therefore investigated recombination events taking place in the
area surrounding the HFE locus in two fully informative mouse backcrosses. These
studies allowed us to identify two clearly documented gene conversion events in female
meiosis in a survey of 23,573 potential sites in the mouse. The occurrence of gene
conversion at detectable frequencies in both mice and humans in the context of these
studies suggests that gene conversion is a very significant contributor to haplotype
evolution in mammals and that haplotypes which occur as a consequence of gene
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conversion may have great potential utility in identifying the locations of genetic variants
which contribute to human phenotypes with complex inheritance patterns.
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INTRODUCTION
Haplotype-based association studies offer great potential for the identification of
loci contributing to human complex trait phenotypes. The mechanisms that contribute to
the evolution of new haplotypes in the human genome are thus of interest and importance
in understanding the most effective use of this powerful methodology. Biological
mechanisms that shape haplotypes include mutation and meiotic recombination. The
term recombination encompasses two types of events that both result in the exchange of
chromosomal segments. These include crossover events, in which chromosomal
segments undergo reciprocal exchange, and gene conversion events, involving the
unidirectional transfer of genetic information from a donor chromosome that itself
remains unchanged.
Sites of crossover are referred to as recombination hotspots (RHS). These RHS
are restricted to punctate regions along the genome which form the boundaries of
haplotype blocks. In addition to crossover events, gene conversion events are also known
to occur at these hotspots in mammals as well as in lower eukaryotic organisms.
Our ability to investigate the impact of recombination on haplotype evolution is
often restricted by our inability to observe these events in real time and by the difficulty
in specifically identifying how groups of chromosomes are related through generations of
human history. We have taken two approaches, the first in humans and the second in
mice that have allowed us to compare chromosomal blocks with a defined point of
common ancestry. We used these approaches to study recombination events and show
that both crossover and gene conversion events have significant impact on haplotype
evolution.
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To study these events first in human chromosomes, we collected chromosomes
that are identical by descent because they carry a unique disease-causing mutation and
are thus related to each other over finite historical periods in the regions immediately
surrounding the mutation. We have taken this approach to investigate haplotype
evolution in the region of chromosome 6p21.3 surrounding the HFE gene. HFE contains
a group of disease-causing mutations that include two major mutations, C282Y and
H63D, which are associated with hemochromatosis, a disease of iron-overload. The
C282Y mutation is thought to have a single origin, and thus chromosomes marked by this
mutation share a single common ancestor. Given the relatively young age of the
mutation and its single origin, we have analyzed haplotypes in C282Y-carrying
chromosomes in order to identify gene conversion events. In addition, we analyzed
haplotypes surrounding the older H63D mutation to demonstrate the possibility for the
spread of this disease allele via gene conversion.
Our ability to observe recombination events in humans is limited by our inability
to directly observe these events in real experimental time. To address this issue and to
investigate the possibility of gene conversion events not limited to recombination
hotspots, we looked at the inheritance of haplotype in DNA isolated from backcrossed
progeny resulting from two crosses from genetically divergent strains of mice. Here we
were able to directly track the inheritance of markers over a single generation to monitor
recombination events in the area we examined. In both these systems, we examine the
two types of genetic recombination events and their contribution to haplotype evolution.
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MATERIALS AND METHODS
DNA samples. Human: Diversity panel of 31 ethnically diverse human DNA
samples were obtained from Coriell Cell Repositories (Camden, NJ,
http://locus.umdnj.cdu/ccr/). NA00522: Kikuyu, NA00726: Korean, NA01850: African
American, NA02064: Ghana, NA02347: Swedish, NA02430: Italian, NA02476: Zulu,
NA02743L Greek, NA02783: Iranian, NA03043: !Kung, NA03579: Cuban, NA03580:
Greek, NA03721: African American, NA03780: Spanish, NA04428: Mexican American,
NA05052: African American, NA03735: African American, NA10418: Finnish,
NA10810: Japanese, NA10923: German, NA10965: American Indian, NA 1321:
Chinese, NA] 1322: Chinese, NA1 1323: Chinese, NA1 1324: Chinese, NA1 1373:
Cambodian, NA11589: Japanese, NA12556: French, NA12558: French, NA14611: East
Indian. Pygmy DNA also obtained from Coriell included NA10494, NA10471,
NA10492, NA10496, NNA10469, NA10470. Primate DNA included: NA03448,
NG03612, NG(03657, NG03610: Pan troglodytes, NG05251: Gorilla gorilla, NG05253:
Pan paniscus, NG06209: Pongo pygmaeus.
The following HFE samples were obtained from Coriell Cell Repositories:
NA13591, NA14180, NA14620, NA14621, NA14628, NA1463, NA14640, NA14646,
NA14650, NA14651, NA14652, NA14654, NA14655, NA14656, NA14657, NA14685,
NA14686, NA14688, NA14689, NA14690, NA14691, NA14702, NA14703, NA14712,
NA14715, NA14857, NA16000. All other HFE samples were provided by N. Andrews
(Children's Hospital, Boston), and R. Chung (Massachusetts General Hospital, Boston).
Population panel DNA was provided by: Kosrae: M. Karayiorgou (Rockefeller, New
York), Basque and Spanish: M. Ramos (U. of Basque Country, Spain), Dutch: F. Baas
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(Academic Medical Center, Amsterdam), African American: A. Menon (University of
Cincinnati, Cincinnati), Vietnamese: E. Schurr (McGill University, Montreal).
Venezuela DNA and kindred information (Wexler et al., 2004) was provided by the
Hereditary Disease Foundation (Rockefeller, NY). When applicable, DNA from whole
blood was isolated using a phenol/chloroform extraction protocol. Genome-wide
amplification using GenomiPhiTM was performed to increase DNA yield when necessary.
Mouse: Mouse DNA was provided by: R. Swank (Roswell Park, Buffalo).
Control DNA for mouse was obtained from Jackson Laboratories (Bar Harbor, Maine)
including PWK/PhJ (003715), C57BL/6J (00664), and Spret/EiJ (001146).
SNP Discovery. Human: SNP discovery in the human HFE locus was
performed by sequencing three samples derived from a C282Y homozygote, a C282Y
heterozygote, and a H63D homozygote. Overlapping primers pairs flanking 400-600 bp
regions were designed to cover a total of -50 kb surrounding the HFE gene. Two
regions (of approximately 500 bp each) were eliminated due to the presence of
pseudogene-like sequences that would make unambiguous genotyping difficult. SNPs
significant for either mutation-carrying chromosome were selected for analysis.
Chimpanzee (pan troglodyte) sequencing was also performed or chimp genome sequence
(recently available) was used to designate the "ancestral" reference allele at each SNP.
Mouse: SNP discovery in the mouse HFE locus was made by sequencing -3 kb using
overlapping primer pairs flanking 400-600 bp of non-repeat sequences in regular
intervals across 1 MB surrounding the HFE locus. Sequencing was performed in DNA
from PWK/Ph and Spret/Ei strains. C57BL/6J sequence was also obtained or the
database sequence was referenced.
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Genotyping. Human: PCR amplification of a 500-1000 bp region surrounding
each SNP was performed in 96-well format using a thermocycler with a final reaction
volume of 12-50 kl. PCR products were then denatured and spotted onto Hybond N+
membranes (two identical membranes per PCR plate). Allelic discrimination was
performed by using allele-specific oligo (ASO) hybridizations. ASOs were designed as
17-mers with the allele of interest in the 9th position. Each membrane was then probed
using an ASO labeled with y33P. Membranes were hybridized for 1.5 hr-overnight at 54°
C, washed, and exposed to phosphor screens for subsequent visualization. Images were
acquired using a Storm Phosphoimager ® (GE) after 24 hours of exposure and analyzed
visually or with ImageQuant ® software (GE). Mouse: Mouse genotyping was
performed by KBioscience (Hoddesdon Herts, UK).
Resolution of haplotypes. Haplotypes were resolved when pedigree information
was available to allow the unambiguous assignment of genotypes to each of the two
chromosomes. This was possible in the samples from the large Venezuelan cohort using
pedigree information for extended kindreds. Haplotypes were determined manually by
assigning each allele to one of two parental chromosomes using genotype information for
each parent, child, or extended family member. Each parent's contribution to the child's
haplotypes was determined. Whenever possible, this was done by identifying
homozygous sites in an individual. For example, in the simplest scenario, a parent may
have two identical haplotypes, homozygous at every site examined. In such a case, this
parent must have contributed one of these two homozygous haplotypes to the offspring.
By subtracting this haplotypes from the summed haplotypes (represented by genotype
information for each SNP marker) of the offspring, the remaining haplotype would be
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that haplotype contributed by the other parent. This parent's second haplotype would
then be determined by subtracting the haplotype donated to the child from the parent's
summed haplotypes.
HapMap data deriving from the CEPH (Centre d'etude du polymorphisme
humain) population collected for human genetic mapping studies of Utah residents with
northern and western European ancestry (Altshuler et al., 2005) was also performed.
Each haplotype was manually subtracted by comparison of triads (mother, father, child).
Phased haplotypes were determined using genotype data, and no call was made whenever
resolution could not be unambiguously made.
RESULTS
Identification of a local recombination hotspot in the human HFE locus
In an effort to develop a high-resolution picture of haplotypes found in the region
surrounding the HFE locus, 41 SNP markers were genotyped in this region. These SNPs
span a genomic region of 45.8 kb on 6p21.3 that includes two histone genes, histone
1 H4c and histone Hlt, which are downstream of HFE. The arrangement of these SNP
markers in relation to the genomic locus is shown schematically in Figure 1. These SNP
markers were selected from an original group of 44 SNP markers that were found by
sequencing three individuals, a homozygote and a heterozygote for the C282Y mutation,
and one homozygote for the H63D mutation. Information about each marker is shown in
Table 1. The name of each SNP used in this study along with corresponding reference
SNP ID numbers (rs#) assigned by NCBI (National Center for Biotechnology
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Information) in the SNP public database (dbSNP) is shown. The SNPs used in the
analysis of each population in this study is also indicated in Table 1.
We genotyped the 41 SNPs indicated in a collection of 32 individuals from
diverse ethnic and racial backgrounds (this collection of samples will henceforth be
referred to as the diversity panel). The genotype patterns for these individuals are shown
in Figure 2. Each column represents one individual, whose two chromosomes are shown
together in a single column. The genotype at each diallelic SNP marker is represented by
a colored box. Green was used to represent homozygosity for the reference allele at a
SNP, while red was used to represent homozygosity for the alternative allele at a SNP. A
blank box indicates that no genotype was available for that site. The "ancestral" allele of
each SNP, as determined by chimpanzee (pan troglodyte) sequence, was designated the
reference allele whenever this information was available. (In the rare case in which this
information was not available, the reference allele is arbitrarily assigned to correspond to
the Genbank sequence). Blue was used to represent heterozygosity for both alleles at that
particular marker.
Two major haplotypes (designated A and B in Figure 2) in the region from SNP
487 to SNP 525 (shown between brackets) became evident by grouping individuals with
similar genotype patterns together. These chromosomes were arranged according to their
genotypes within this block, to illustrate the presence of two major homozygote groups
above SNP 525. These groups carry two chromosomes with the same haplotypes
(marked as A/A and B/B in Figure 2). A third group of chromosomes with many
heterozygote genotypes presumably results from individuals with an A haplotype on one
of their chromosomes and a B haplotype on their other chromosome (designated A/B in
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Figure 2). The two homozygote groups above SNP 525 are associated with more than
one haplotype below. In addition, several individuals with the heterozygote block above
SNP 525 have a homozygote block below this SNP. This suggests the presence of a local
site of crossing over, or a recombination hotspot (RHS), somewhere below SNP 525.
Historical crossovers at this hotspot would explain the apparent swapping of modular
chromosomal blocks that would lead to these results.
In an effort to further locate sites of crossing over positioned within the region
surrounding the HFE locus, we looked for chromosomes with clear evidence for
historical recombination within a cohort of kindreds from Venezuela. 30 SNPs, shown
schematically in Figure 3, were genotyped and used in this analysis. Recombinant
chromosomes were defined specifically as those in which a single homozygous block is
preceded or followed by a single heterozygote block in the region we genotyped. Our
rationale was that this type of pattern would most likely arise from historical crossover
events that occurred at the boundary between these two blocks. Information from
recombinant chromosomes was isolated and each recombinant was classified according
to the position of the apparent site of crossover. We totaled the number of unique
recombinant types for crossovers occurring at each site observed. This is shown
graphically in Figure 3, in which the height of each peak indicates the number of
recombinant types of chromosome at each site. We reasoned that totaling each type of
recombinant would offer insight into the number of historical crossover events that
occurred. As shown in Figure 3, the largest number of recombinant patterns (9 types)
was found between SNP 525 and SNP 532-(H63D). The second largest number (6 types)
was found close to this site between SNPs 532b-3 and 532-2 (see Figure 3). The third
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largest number (3 types) was observed between SNP 536 and SNP 538. These findings
support the localization of a local site for crossing over below SNP 525.
To corroborate our findings with data derived from other populations and to
confirm that our analysis is valid over an extended chromosomal region, we analyzed
blocks of genotyping data recently made available from the HapMap project (public
release #19, 10/24/05, http://hapmap.org) (Altshuler et al., 2005) from the same region of
chromosome 6. Figure 4 shows a selection of genotype data from Japanese chromosomes
arranged with SNPs running 5' to 3'. Using this data we illustrate the presence of four
recombinant chromosomes (each indicated by a * in Figure 4) defined by the presence of
a single heterozygote block and a single homozygote block. These recombinant
chromosomes are shown alongside non-recombinant chromosomes to demonstrate that
the boundaries of apparent crossover for two of these chromosomes are in the same
location as we observed in our data (see large arrow in Figure 4). Two additional
recombinant chromosomes with sites for crossing over outside of the region we examined
are also shown for comparison. On Figure 4, the region corresponding to the location of
our own analysis is shown by a bracket. We also include SNP markers extending out a
total of 140 kb (distance from topmost SNP to bottommost SNP).
HapMap reports of local recombination rates modeled using genotype data
(Myers et al., 2005) also confirms our findings of an elevated region of recombination in
the region we examined. Table 2 lists the recombination rates (from hapmap.org)
reported between markers as shown (SNPs that are common to both our analysis and the
HapMap analysis are designated with both SNP names). Recombination rates are
summarized in the last two columns and given as a rate (cM/MB) and genetic distance
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(cM). These values are given between the "starting" SNP (shown in the left group of
columns) and the "ending" SNP (shown in the middle group of columns). Elevated
recombination rates (highlighted yellow in Table 2) above SNP 532-1(H63D) confirms
our finding. Interestingly, HapMap also reports a second elevated region of
recombination between SNPs 532-2 and SNP 542. This region encompasses an area
where we also note a historical recombination activity, as shown by the third highest peak
in Figure 3 between SNPs 536 and SNP 538. These data together suggest a cluster of
local recombination activity in this region.
To place these locally elevated recombination rates in context of genome-wide
recombination activity, we also searched HapMap estimates of genome-wide
recombination hotspot reports (Myers et al., 2005). These data do not report a
recombination hotspot in this area. The nearest reported hotspots, in fact, lie over 400 kb
upstream and over 40 kb downstream from the HFE gene. This indicates that either
recombination was not detectable using their methodology and/or that the local regions of
elevated recombination (henceforth referred to as local RHS) are relatively cold areas for
crossing over in relation to a genome-wide measurement of recombination.
Gene conversion events lead to the creation of new haplotypes
The next step in this project was to investigate the occurrence of gene conversion
events in the HIFE locus by comparing chromosomes that are identical by descent because
they carry a shared disease-causing mutation. Previous work in our group has shown that
this strategy is an especially effective way of demonstrating recombination events in
human chromosomes. This work examined a region of chromosomes 7q31 surrounding
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the AF508 mutation of the CFTR locus responsible for cystic fibrosis and found evidence
for gene conversion events not limited to local sites of crossovers (Keen Kim, 2002). In
order to apply this methodology to the HFE locus, we analyzed haplotypes on
chromosomes marked by the C282Y mutation in the HFE gene. We genotyped 42 SNP
markers (shown in Table 1) spanning the same 45.8 kb region in DNA from 39 patients
homozygous for the C282Y mutation to identify shared haplotypes in this region. These
genotypes are presented in Figure 5a. The SNPs used in this analysis are shown
schematically in Figure Sb.
C282Y is thought to have a single occurrence in history (Feder et al., 1996) and
thus each C282Y-carrying chromosome is expected to be identical by descent on the
haplotype that immediately flanks this mutation. While this was the case for the majority
of chromosomes we genotyped, we also found a new haplotype created by nucleotide
sequence changes (arrows labeled GC, Figure a and c). These sequence changes were
noted at SNP 563 and SNP 565-2. The region between these SNPs spans approximately
1.5 kb and is located between HistlH4c (about 1.7 kb upstream) and HistlHlt (about 1.3
kb downstream). The concordant change of two SNPs in a region of less than 2 kb is
consistent with the properties of a gene conversion event. Notably, these events were not
found at the local RHS for crossing over described above.
We considered alternative explanations to the gene conversion scenario observed
at this site. L)e novo mutation appears to be an unlikely explanation for these results.
The sequence changes seen in our C282Y haplotypes are not found at CpG hotspots for
mutation. The genome-wide mutation rate for non-CpG sites in the human genome has
been estimated to be approximately 1-2.7 x 10-8 per nucleotide per generation (Nachman
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and Crowell, 2000). The history of the C282Y mutation (previous studies have estimated
that the C282Y mutation arose between 62 and 250 generations ago based on extended
haplotype analysis (Distante et al., 2004)) suggests that chromosomes which carried the
C282Y mutation would not have been transmitted through enough generations to be
likely to have accumulated one, let alone two de novo mutations.
A single crossover at the local RHS described above found beneath C282Y
(between SNP 536(C282Y) and SNP 538) could be used to explain our finding if we
could identify a haplotype identical to the C282Y haplotype at all sites except for the
mutation and the stretch of observed sequence change. The closest such haplotype is
shown in Figure 6 on the chromosome labeled 3721 Afric Amer. One finding argues
strongly against a crossover at this site. A single SNP, SNP 547, found through
sequencing of a C282Y homozygote, was seen only in C282Y chromosomes. The allele
frequency of this SNP in the diversity panel in chromosomes not carrying C282Y was 0
(see Figure 6). This SNP is therefore likely to be a mutation that occurred close in time
to the C282Y mutation on an ancestral chromosome carrying C282Y. The absence of
this SNP in the candidate African American chromosome makes it unlikely that a
crossover occurred below at the hotspot between SNP 536(C282Y) and SNP 538
producing the observed result. A crossover occurring below this site is even less likely
given the recombination data presented above.
The remaining mechanism consistent with the novel haplotype, gene conversion,
involves the unidirectional transfer of genetic information from one haplotype to another.
In order for the novel haplotype to have arisen via gene conversion-, the appropriate
donor sequences must be present on a non-C282Y haplotype Figure 6 shows the
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genotypes from a subset of individuals from the diversity panel, with SNP markers
common to those genotyped in the C282Y homozygotes shown. 30 chromosomes are
shown that carry the appropriate SNP alleles between SNP 563 and SNP 565-2 that could
serve as donor alleles for the event noted at these SNPs (arrow, right panel). This
indicates that chromosomes that carry the appropriate reservoir sequence which can be
transferred onto the C282Y haplotype through gene conversion are present in these
populations.
Although we had observed only a single gene conversion event in the C282Y
chromosomes we had studied, we wished to make a quantitative estimate of the sample
size surveyed to identify this event, which in turn would suggest an estimate of the
frequency with which a gene conversion event outside a recombination hotspot might
occur. The selection of chromosomes specifically marked by the C282Y mutation
suggests that the stretch of haplotype immediately surrounding the mutation derives from
a single common ancestor. The data in Figure 6 support that assumption. To estimate the
number of generations we have surveyed, we make the assumption that the chromosomes
we have surveyed are related to each other by a star shaped genealogy in which each
chromosome is related to the ancestral chromosome by an independent path. This
assumption clearly contributes to an overestimate of the number of generations surveyed,
since the chromosomes we are sampling may well have more recent common ancestors.
The estimated age of the C282Y mutation, ranging from 62 to 250 generations (Distante
et al., 2004), gives a common denominator with which we can make an estimate
regarding the frequency of gene conversion events given the number of generations
which have passed since the C282Y mutation occurred. The size of the sample in which
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we observed the gene conversion event was a survey of 42 SNP sites in 39 homozygotes
for the C282Y mutation. We thus estimate that we surveyed a total of 3276 sites total
(given 2 chromosomes per individual). Our observation of gene conversion would thus
be consistent with a frequency of gene conversion at non recombinant hotspots of 1.2-4.9
x 10-6 per site per generation or higher (given the limitations of the assumption of a star
shaped genealogy). This result suggested that gene conversions not limited to
recombination hotspots could occur with a high enough frequency to lead to the creation
of new haplotypes within haplotype blocks.
To test this theory we used genotype data from the HapMap project and manually
resolved haplotypes from 30 trios (father, mother, child). Thus far we have inferred
haplotype structure from genotype information derived from the two chromosomes of
each individual. Parental genotypes allow us to determine the phased haplotypes on each
of these two chromosomes at most sites. We used data from 180 SNP markers spanning
141.2 kb in a population residing in Utah with northern and western European ancestry
originally collected by the Centre d'etude du polymorphisme humain (CEPH) for human
genetic mapping studies. 40 of these haplotypes are shown in Figure 7. Putative
historical gene conversion events are shown (solid arrows) that change a haplotype block
at the site indicated. Interestingly, two of the sites shown involve coordinate changes of
less than 1 kb (834 bp and 291 bp), highly suggestive of a conversion tract. These
findings are not likely to be due to genotyping error since these data were generated by
comparing genotypes of three individuals in a parent offspring trio. When any
disagreement of genotypes caused by possible genotyping error was found, the trio with
these disagreements was eliminated in the analysis for that marker.
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Gene conversion events directly observed over a single generation in progeny of two
large mouse backcrosses
The significance of gene conversions in shaping haplotypes over time depends on the
frequency with which these events occur over a single generation. When observing
human chromosomes for recombination events, we are limited by the fact that we are
observing a snapshot of chromosomes that have evolved over generations of time. Our
crude estimation of gene conversion frequency for example, was dependent upon age
estimates of the C282Y mutation and assumptions regarding the genealogical
relationships among the chromosomes surveyed. For chromosomes with even less well
defined relationships, assessing the dynamics of gene conversion are even more
challenging.
We therefore sought to develop a system in which we could directly observe the
occurrence and transmission of gene conversion events in a mammalian model system in
real experimental time. To accomplish this goal we have followed the inheritance of a
series of SNP markers tightly linked to the mouse HFE locus over a single generation
using progeny from two large interspecific mouse backcrosses. 658 N2 samples from
((PWK x C57BL/6J-gm/gm) x C57BL/6J-gm/gm) backcrosses and 570 N2 samples from
((M spretus x C57BL/6J-gm/gm) x C57BL/6J-gm/gm) backcrosses were collected. The
breeding scheme and summary of samples used is shown in Figure 8a and b. These
samples were genotyped for 20 SNPs spanning 1 MB of chromosome 13 containing the
mouse HFE locus. These SNPs are shown schematically in Figure 9a and listed in Table
3. SNPs were identified by sequencing a PWK, M Spretus, and C57BL/6J homozygote,
respectively. All 20 SNPs had one allele in the C57 strain and an alternate allele that was
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shared by both the M Spretus and PWK strains. 12827 successful genotypes were
obtained from progeny samples deriving from the (PWK x C57BL/6J-gm/gm) x
C57BL/6J-gm/'gm backcross, while 10926 successful genotypes were obtained from
progeny samples deriving from the (M spretus x C57BL/6J-gm/gm gm) x C57BL/6J-
gm/gm backcross.
Gene conversion candidates were readily detected using our strategy (see Figure
8a, II). In order to examine whether these events were limited to recombination hotspots,
crossover events were also noted by the continuous change of marker alleles (see Figure
8a, III). These crossovers are shown in Figure 9a and were detected between SNPs
JK_29 and JK32 (8 such events occurring at this site were detected in progeny from the
PWK x C57BL]/6J backcross), and one event was detected between JK_06 and JK_08 (in
M Spretus x C57BL/6J backcross). Other events were apparent between JK_32 and
JK_36 (4 events in M Spretus x C57BL/6J backcross), but these seen in the terminal
SNP genotyped, so further downstream genotyping needs to be performed to rule out
possible gene conversion.
Of the 23753 total genotypes obtained, two gene conversion candidates were
observed and genotyping error was ruled out by direct sequencing. Both conversion
events did not occur at the sites of crossover detected in other samples (above). These
conversion events are shown schematically in Figure 9b. The first conversion event was
observed at SNP JK_08, and seen in one progeny of the ((PWK x C57BL/6J-gm/gm) x
C57BL/6J-gm/gm) backcross. JK_08 is located between two genes (Abtl and Btnlal) on
chromosome 13. Further sequencing of the region located immediately adjacent to this
conversion event showed at least one other SNP marker located 21 bp upstream from
44
marker JK_08 that was also included in the gene conversion tract. The second
conversion event was observed at SNP JK_19 in one progeny of the ((M spretus x
C57BL/6J-gm,/gm) x C57BL/6J-gm/gm) backcross. JK_19 is located between two exons
in the mouse -HFE gene. Further sequencing around this SNP change was accompanied
by at least 10 coordinate changes observed in SNPs spanning a tract of 604 bp. These
data are consistent with gene conversion tract lengths of less than 1-2 kb reported in other
gene conversion studies (Guillon and de Massy, 2002; Jeffreys and May, 2004). Further
sequencing will allow us to determine the outer boundaries of each conversion tract.
H63D is found on multiple haplotype backgrounds, suggesting transfer via a gene
conversion-like mechanism
The high frequency with which gene conversion events were observed lead us to
support the hypothesis that these events could serve as a viable mechanism for the spread
of disease alleles in a population. Currently, when a disease-causing mutation is found
on more than one haplotype background, a common explanation offered is that these
mutations occurred independently at the same site. Given the low frequency of mutations
at non-CpG nucleotides, however, this model becomes less likely as more haplotypes
carrying the mutation are found. Another mutation in the HFE locus, H63D, is one such
mutation that is found with high frequency throughout the world (Distante et al., 2004)
and reports have placed it on different haplotype backgrounds (Rochette et al., 1999). In
the present study we examined several different populations using a high-resolution scale
to determine whether we can detect H63D on different haplotypes immediately
surrounding the mutation.
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We genotyped 464 individuals (928 chromosomes) from different populations as
summarized in Table 4. We found 7 H63D homozygotes and 58 H63D heterozygotes
among these samples. Using these samples, we defined each major haplotype by the
coordinate change of 2 or more SNPs in a block above or below the H63D mutation.
Since these chromosomes were derived from unrelated individuals, we could only resolve
haplotypes from genotype data unambiguously in H63D homozygotes or in those
chromosomes carrying homozygote blocks. Nevertheless, as shown in Figure 10, these
chromosomes were sufficient to confirm that H63D can be found on multiple haplotypes
within a short-range distance from the mutation. Figure 10 shows just three samples
which together illustrate H63D on multiple haplotypes. The majority of H63D
chromosomes we examined were associated with one of the two major haplotypes shown
in this figure (leftmost and rightmost, top). An additional major haplotype below the
mutation can be deduced from the H63D homozygote sample (Sp1 815) shown with
heterozygous sites below the mutation. In total, we observed at least two major
haplotypes within 10 kb above the mutation, and two major haplotypes within 17 kb
below the mutation.
We then turned to chromosomes derived from related individuals in order to
unambiguously assign haplotypes surrounding the H63D mutation. In a large
Venezuelan pedigree, we analyzed 89 individuals (out of a total of 755 examined)
including 15 homozygotes and 74 heterozygotes for the H63D mutation. Using extended
family information, we resolved haplotypes in these chromosomes and isolated those
carrying the 1-163D mutation. Among these, we found one major haplotype block below
the H63D mutation and two major haplotypes, labeled A and B in Figure 11 above the
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H63D. A third haplotype block B', (far right in Figure 11) likely results from a gene
conversion at SNP 500-2 on haplotype B. Of the 104 haplotypes carrying H63D that we
examined, we observed 20 A haplotypes, 81 B haplotypes, and 3 B' haplotypes.
We also selected H63D-carrying chromosomes from the HapMap data set
(Altshuler et al., 2005) and performed a similar analysis using data from trios of the
CEPH population of Utah. These resulting haplotypes are shown in Figure 12. Using
genotype information from 101 SNP markers covering a region of 141.2 kb, we found
two major haplotype blocks (labeled A and B in Figure 12) above H63D that correspond
to the two haplotypes seen in Venezuela. In the CEPH population we also observed a
third major variation of haplotype A (far left column). We also found at least three major
haplotypes below H63D and a fourth minor haplotype shown to the far right on Figure
12. Each major haplotype above H63D (A and B) was associated with more than one
major haplotype below H63D. If we include other minor haplotypes (likely produced by
gene conversion events) with variations at one or more nucleotide changes, there are as
many as 5 haplotypes above H63D within 5 kb (with 7 within 20 kb) and as many as 5
haplotypes below H63D within 11 kb of the mutation.
Given the large number of haplotypes on which we found H63D, it is unlikely
that this finding is due to recurrent mutation. A second possibility is that crossovers
carried H63D from one framework haplotype to another. H63D is found right at the
boundary of two regions with elevated recombination fractions, see above and Figure 12.
As shown schematically in Figure 13, a single occurrence of the H63D mutation in
history followed by crossovers above and below H63D could account for the four
haplotypes seen in the CEU chromosomes (haplotypes: Ax, Bx, Ay, By). For H63D to
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move from haplotype A-x to B-y by crossover alone, a minimum of two sequential
crossovers would be necessary to give these results (from A-x to B-x, then from B-x to
B-y). The probability that such a double crossover would occur can be represented by the
product of the recombination frequencies above H63D and below H63D. To compute
these frequencies, we summed the genetic distance in cM from the first informative
marker (distinguishing haplotype A from B) above H63D (at marker rs 2794719, 2289 bp
above the mutation) to H63D, and the first informative marker below H63D (rs 6918586,
6205 bp below the mutation) to H63D. Recombination rates from HapMap, as shown in
Table 2 were used for these computations. A rate for marker rs 6918586 was not
available, so the closest available marker, rs 1150660, located 10.2 kb from H63D was
used. The recombination distances, given as the sum of distances of intervening markers,
was 0.004 cM above H63D and 0.008 cM below H63D. Therefore, the crossover
frequencies at these sites are given by 4 x 10-5 crossovers per generation above H63D and
8 x 10-5 crossovers per generation below H63D. To produce three of the four haplotypes
shown by crossover events alone, two sequential crossovers (once above H63D followed
by once below H63D) would happen at a frequency of approximately 3.2 x 10-9 per
generation.
Instead, given the high frequency with which we observed gene conversion events
in our mouse experiment, this mechanism, either alone or accompanying a single
crossover event, becomes a much more attractive explanation for the spread of the H63D
mutation onto different haplotype backgrounds.
48
DISCUSSION
Gene conversions have been well studied in yeast and lower eukaryotes in which
all four products of a single meiotic event can be directly recovered. Studies of meiotic
gene conversions in mammals, on the other hand, is exceptionally challenging precisely
because of our inability to isolate the products of a single meiosis. We have taken two
approaches that have allowed us to better observe these events in mammalian systems.
First, we chose to examine chromosomes marked by a disease-causing allele, C282Y of
the HFE locus. This mutation has been reported to lie on an extended haplotype
framework and most studies estimate that the mutation arose between 62-77 generations
ago (the full range of age estimates of C282Y extend from 62-250 generations) (Distante
et al., 2004). We have examined markers within 25 kb upstream and downstream of the
C282Y mutation, where infrequent events such as mutations, have not had significant
time to adequately erode LD between surrounding markers. We find, instead, evidence
of gene conversion events, shown by the coordinate change of a short stretch of sequence
approximately 1.5 kb in length. We found 1 event in two chromosomes in 42 SNPs
sampled across 78 chromosomes, leading us to estimate these events on the order of 1.2-
4.9 x 10-6 per site per generation. A previous study in our group in the CFTR locus using
chromosomes homozygote for the AF508 mutation, estimated gene conversion events
occurring within the bounds of two hotspots at a rate of 8.3 x 10-7 events per site per
generation (Keen Kim, 2002). This estimate, subject to the same caveats regarding
genealogical history and age of the AF508 mutation, nevertheless is of the same order of
magnitude as our estimate for the HFE locus of 1 gene conversion event in 106 per site
per generation.
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To illustrate that these events shape haplotypes within a haplotype block, we
resolved haplotypes in trios from the CEPH population of Utah. Using a selection of
samples with similar haplotypes, we illustrate that two haplotypes can differ by short, (<1
kb) tracts of allelic change, highly suggestive of gene conversion events (Figure 7).
These haplotype differences can lead to the eventual creation of new haplotypes by these
mechanisms as the LD between markers decays over time and these new haplotypes are
propagated in the population.
To directly measure gene conversion events over a single generation, we tracked
the inheritance of markers in progeny from two large mouse backcrosses using markers
spanning MB of the region surrounding the mouse HFE locus. Using this system, we
were able to differentiate gene conversions from double crossovers. Crossovers are
thought to occur only once per chromosome or once per chromosome arm and to exhibit
the phenomenon of interference, in which a single crossover event will deter a second
event from happening nearby. Since we were observing these events occurring over a
single generation, we could rule out double crossovers and clearly identify gene
conversion events.
We observed 2 gene conversion events in 23,753 genotypes surveyed from this
mouse study. From this we make the first estimate of gene conversion occurring in a
single generation in female meioses to be as high as 1 in 104, which is as much as four
orders of magnitude higher than mutation rates for non-CpG sites. The estimation of
female meiotic gene conversion events we made in this region is lower than those
reported for events detected in other regions by sperm typing analysis of male meioses in
mouse and humans. Sex differences may account for the different frequencies we
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observed. In addition to sex differences, however, another major difference between our
study and others reporting gene conversion frequencies is that we report gene conversion
events that are not located at apparent hotspots for crossing over. This finding correlates
with both our human data as well as with recent yeast data supporting the notion that
gene conversions are not limited to crossover hotspots. Thus far in mammalian systems,
however, gene conversions have only been reported at crossover hotspots and the
estimations of frequency of conversion events have also been limited to sites that are also
crossover hotspots. This raises the possibility that gene conversion events occur more
frequently at recombination hotspots, although as we demonstrate, they are not limited to
these sites.
Given the high frequency with which gene conversions may occur at
recombination hotspots, we propose that gene conversion events that happen at the local
hotspot we identified may have lead to the propagation of the H63D mutation onto many
different haplotypes. The high frequency with which we observe gene conversion events
when compared to the low genome-wide mutation rate at non-CpG nucleotides supports
the proposal that gene conversion is a likely mechanism for this observation. It is also
likely that selective pressures may have acted to amplify this effect, such that conversion-
containing chromosomes would persist more than expected in populations. Various
proposals have been made regarding candidate selective forces. One suggestion has been
that the transition from a hunter-gatherer to a farming society made mutations that could
pretect from iron-deficiency anemia beneficial in light of an iron-poor diet (Distante et
al., 2004). Another more intriguing suggestion has been that the HFE protein, expressed
at cell surfaces, may serve as a receptor for an infectious agent (Rochette et al., 1999).
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The H63D mutation might disrupt this interaction, and lead to a selective advantage.
Such possibilities make it plausible that the H63D-containing chromosome was
propagated by both gene conversion and selective pressures.
This study demonstrates the presence of gene conversion events in the HFE locus
that are not limited to sites with elevated crossover activity. Using estimates from human
chromosomes marked by a disease-causing mutations and a direct measurement of these
events in mouse backcross progeny, we demonstrate that gene conversions at these sites
can occur at least as frequently as 1.2-4.9 x 10-6 per site per generation. Given this high
frequency, we propose that gene conversion events, perhaps in the context of selective
pressures, can lead to the propagation of disease alleles, exemplified by H63D, in
populations.
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Table 1: Summary of SNP markers used in each analysis.
The SNP markers used in each analysis is shown. The name of each SNP used in our
study is shown alongside the reference SNP ID (rs#) assigned by the NCBI database.
Columns 3-5 indicate the SNPs used in the analyses of DNA from different populations
as shown.
Table I
NCBI name: Genotyped in Genotyped in Genotyped in Reference Dist from prey
.1K SNP name rs # Diversity panel Venezuela C282Y -/- (chimp) allele Alternate allele Chr 6 position SNP (bp)
485 rs1935235 * * G C 26175760 -
487 rs9358904 * * * G A 26176544 784
489-1 rs9295683 * * * T C 26177473 929
489-2 rs9295684 * * * C T 26177647 174
493 rs9295685 * * * G C 26179703 2056
494 rs9968910 * * A C 26180073 370
495 rs9366634 * * G C 26180374 301
495-2 rs6942196 * * * A G 26180782 408
500 rs807205 * * * G C 26183013 2231
500-2 rs1539183 * * * G C 26183029 16
501' rs9393684 * * * C G 26183509 480
505 rs9358905 * * * A T 26185817 2308
505-2 rs10946805 * * C T 26185869 52
515 rs9295687 * * * C T 26190688 4819
516' rs4529296 * * * G C 26191113 425
517 rs9379825 * * * C A 26191849 736
521-2 rs1971508 * * * C A 26193785 1936
522 rs2006736 * * * T C 26193995 210
524 rs2794720 * * * G C 26195180 1185
525 rs285899.3 * T A 26195834 654
532-l(H63D) rs1799945 * * * C G 26199157 3323
532b-3(S65C) rs180073() * A T 26199163 6
5:32-2 rs2071303 * * * T C 26199314 151
534 rs807208 * N/A:C T 26200125 811
536(C282Y) rs 1800562 * * * G A 26201119 994
536-2 rs1800758 * * G A 26201214 95
538 rs2858996 * * * G T 26202004 790
538-2 rs2071302 * * T C 26202108 104
542 rs707889 * * * G A 26203909 1801
550 rs1150659 * * * G A 26208001 4092
553 rs1 150660 * C A/- 26209418 1417
555 rs198857 * * C G 26210395 977
556 rs1543680 * * * G A 26211155 760
557 rs198855 * * * T A 26211376 221
558 rs198854 * * * T C 26212035 659
563 rs198848 * * C T 26214303 2268
565 rs198846 * * * G A 26215441 1138
565-2 rs198845 * * * G T 26215768 327
566 rs198844 * * G C 26216260 492
571-2 rs707894 * * A C 26218577 2317
575 rs198840 * * * T G 26220142 1565
575-2 rs198839 * * G T 26220598 456
577 rs198838 * * T C 26221318 720
577-2 rs198837 * * T A 26221376 58
577-3 rs198836 * * A T 26221594 218
#:in these SNPs, the non-chimp allele is designated as reference for the Venezuela panel only
Figure 1: Schematic representation of SNPs in the HFE locus genotyped in human
chromosomes.
41 SNP markers identified through sequencing were used in this analysis. These SNPs
span a 45.8 kb region of a locus on 6p21.3 as shown. Each SNP marker is represented by
an open circle and shown from left to right. In addition to the HFE gene, this region also
includes two histone genes: 1H4C and Hlt, respectively, downstream from HFE as
shown. (See also Table 1).
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Figure 2: Genotypes of individuals in diversity panel to demonstrate location of local
recombination hotspot.
The genotypes of the 32 individuals from the diversity panel are shown. Each column
represents the two chromosomes of the individual whose ethnic identity is shown above.
SNPs run from top to bottom (see Figure 1 and Table 1 for a summary of these SNP
markers). The genotype at each SNP is represented by a color. Homozygosity for the
reference allele (1/1) at each SNP is illustrated with a green box. Homozygosity for the
alternate allele (2/2) is shown with a red box. A blank box indicates that no genotype is
available for that site. Heterozygosity at a SNP (1/2) is represented by a blue box.
Individuals with similar patterns are arranged together revealing two groups with largely
homozygous blocks of SNPs in the area indicated by a bracket (between SNP 487 and
SNP 525). These two groups are shown as A/A and B/B above. A third group, with
many heterozygous sites, most likely consists of individuals carrying one A haplotype
and one B haplotype (shown as A/B) above. Each block above SNP 525 is associated
with more than one block below (shaded region), suggesting the presence of a local site
where historical crossover events have occurred, shown by the arrow as a recombination
hotspot (RHS).
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Figure 3: Location of apparent sites of crossing over determined by the number of
recombinant chromosomal types observed in Venezuelan chromosomes
SNPs used in this analysis are shown schematically above in relation to the HFE locus
and as tick marks below the graph. The graph indicates the location of apparent sites of
crossing over determined by recombinant chromosomes in a large Venezuelan pedigree.
Peaks were placed midway between the two SNPs between which recombination was
observed. The height of each peak correlates to the number of recombinant chromosomal
types observed at each location. The largest peak was observed between SNP 525 and
SNP 532-1(H63D) with 9 recombinant types, and the second tallest peak was observed
between SNP 532-1(H63D) and SNP 532b-3(S65C) with 6 recombinant types. [Note
that there is a minor peak adjacent to the second tallest peak that falls between SNP 532-
1(H63D) and SNP 532b-3(S65C)]. The third tallest peak was observed between SNP 536
and SNP 538 with 3 recombinant types.
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Figure 4: Genotypes from HapMap Japanese panel to demonstrate location of local
recombination hotspot.
Genotypes from HapMap are shown in a selection of chromosomes from the Japanese
panel with SNPs running from top to bottom and each individual's two chromosomes
summed by a single column. Non-recombinant homozygous chromosomes are shown
alongside four recombinant chromosomes (each indicated by a *), two of which
demonstrate an apparent site of crossing over in the region we identified (shown as RHS,
large arrow). The other two sites of crossing over are indicated by the open arrows.
Brackets indicate the region studied in our analysis with corresponding SNP names
shown to the right.
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Table 2: Recombination rates in the region we examined from HapMap dataset.
Where available, the SNP names used in our analysis are shown next to the
corresponding NCBI SNP designation (rs#). The recombination rate, given in cM/MB
between the starting SNP and ending SNP is shown in column 7. The corresponding
genetic distances, given in cM, is shown in column 8. Regions with elevated
recombination are highlighted in yellow. These regions correspond to the local sites RHS
we identified. The rates shown on this chart are available from http://hapmap.org.
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Figure 5a: Genotypes of C282Y homozygote individuals showing nucleotide
sequence changes suggestive of gene conversion.
45 SNP markers spanning a 45.8 kb region are arranged from top to bottom; the
schematic of SNPs from Figure 5b is shown vertically to illustrate the position of each
SNP relative to each other. The position of SNP 536(C282Y) is shown with an open
arrow. Note that all haplotypes in the region are identical except for the short stretch of
change resulting in heterozygosity at SNP 563 and SNP 565-2, indicated by the arrow.
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Figure 5b and 5c: Schematic representation of SNPs genotyped in C282Y
homozygote individuals showing location of SNPs affected by putative gene
conversion event.
Each SNP marker is represented by an open circle and shown from left to right in relation
to the genes in this locus. The stretch of SNPs affected by the gene conversion event is
represented by filled circles in 5c.
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Figure 6: Candidate donor chromosomes form the diversity panel that carry the
appropriate haplotype from SNP 563 to SNP 565-2 that could produce the resultant
gene conversion event observed in C282Y homozygotes.
A C282Y homozygote is shown at the far left, and the C282Y homozygote with the gene
conversion event is shown to its right. The gene conversion event spanning SNPs 563-
565-2 would require a pattern of three green homozygote SNPs in the donor
chromosome. Such candidate donor chromosomes are shown to the right with the
appropriate SNPs circled (arrow).
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Figure 7: Haplotypes resolved from HapMap genotype information of CEPH UTAH
panel of trios to illustrate putative gene conversion events that can lead to haplotype
evolution.
Genotype data from HapMap was used to manually resolve haplotypes for 180 SNP
makers spanning 141.2 kb centered on the HFE locus. Chromosomes were derived from
the CEPH population in Utah (northern and western European ancestry). Arrows show
putative gene conversion events indicated by punctate sequence changes. Two of these
events involve the coordinate changes of several markers within a 1 kb interval highly
suggestive of gene conversion as shown. Arrows in parentheses indicate possible sites of
gene conversion events that may alternatively or additionally result from crossover
events, suggested by the coordinate change of several markers in the same haplotype.
One CpG site at a candidate SNP is indicated.
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Figure 8: Strategy for identifying recombination events in two large backcrosses.
a: Schematic to illustrate strategy.
Samples were collected from a ((PWK x C57BL/6J-gm/gm) x C57BL/6J-gm/gm)
backcross and from a ((M spretus x C57BL/6J-gm/gm) x C57BL/6J-gm/gm) backcross,
shown schematically. Recombination events were directly observed by genotyping 20
SNP markers covering 1 MB of chromosome 13q. This region is illustrated as stretches
of red or green. The results expected from this strategy are shown below. I. No
recombination events in the region; II. Gene conversion events in which only a short
stretch of markers change from expected; III. Crossover events in which a contiguous
portion of the region examined changes from expected.
b: Summary of genotyping analysis for each backcross.
20 markers were genotyped for each sample. The number of successful genotypes
indicated represents those in which an unambiguous genotype could be attributed to the
given SNP marker.
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Figure 9: Schematic representation of SNPs genotyped in mouse chromosomes
showing location of RHS and gene conversions identified.
a: SNPs genotyped in mouse chromosomes.
Each SNP marker is represented by an open circle and shown from left to right. 20 SNPs
span a region of 1 MB on chromosome 13 (see also Table 3). The location of two sites of
crossover with the
number of events observed at each site are shown (RHS).
b: Gene conversions identified.
The same SNP markers are indicated as above. Each filled circle represents a SNP
marker where a gene conversion was observed. JK_ 9 is found in a region with a higher
density of markers that cover the mouse HFE locus, these markers, along with the
corresponding mouse HFE gene, are shown in the inset.
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Table 3: Summary of SNP markers used in analysis on mouse chromosome 13.
20 SNP markers identified through sequencing were used in this analysis. These SNPs 1
MB region of a locus on the syntenic region of mouse chromosome 13 containing the
HFE gene.
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Table 4: Summary of population samples genotyped to demonstrate that H63D can
be found on multiple haplotype backgrounds over a short distance.
The number of individual samples for each population is shown. 7 H63D homozygotes
and 58 H63D heterozygotes were identified.
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Figure 10: H63D-carrying chromosomes illustrate that the mutation can be found
on multiple haplotypes.
Two major haplotypes above H63D were seen in the populations we sampled and shown
here. The haplotype block below H63D as illustrated in the homozygous blocks in the
samples to the far left and far right represents the one most frequently seen in the
populations we sampled. A third haplotype can be inferred from the middle samples, an
H63D homozygote.
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Figure 11: Haplotypes carrying H63D derived from Venezuelan panel.
These three haplotypes represent the three haplotypes carrying H63D in the Venezuela
population. They share a common haplotype block below H63D. Two major haplotype
blocks above H63D are also shown (A and B). A third minor haplotype, B' (far right),
most likely results from a historical gene conversion event at SNP 500-2 that occurred on
haplotype B. Of the 104 haplotypes carrying H63D that we studied, 20 A haplotypes, 81
B haplotypes, and 3 B' haplotypes were observed. Each haplotype was subtracted
manually from chromosomes using genotype and pedigree information.
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Figure 12: Haplotypes carrying H63D derived from CEPH triads HapMap data.
Genotype data was obtained form hapmap.org, and each haplotype was derived manually
using information from each triad. 19 haplotypes are shown, with 101 SNP markers
running from top to bottom covering 141 kb of chromosome 6p21 surrounding the HFE
gene. All haplotypes carry the H63D mutation, as labeled. Above the H63D mutation,
two major haplotypes A and B are present. Below the haplotype, two major haplotypes
are shown as X (with two variations) and Y. Minor variations within each major
haplotype group would also allow us to name further haplotypes on which H63D is found
in this population. The area within the bracket corresponds to the region we studied in
our populations, with corresponding SNP names shown to the right.
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Figure 13: Schematic to illustrate how two sequential crossovers are required if
crossover events alone are used to explain the four major haplotypes observed in
CEPH data given a single occurrence of H63D.
In order to explain the four major haplotypes (AX, AY, BX, BY) seen in CEPH data (see
Figure 12) using crossover events alone, three crossover events are required as shown to
move the H63D mutation from any one haplotype to the other three haplotypes. Two
examples (beginning with AX) are shown. The H63D mutation is represented by a * and
each site of crossover necessary to produce the haplotype combination to the right is
represented by a dotted line.
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Chapter 3
Association analysis of the HFE locus
with residual age of onset in Huntington's disease
90
ABSTRACT
Huntington's disease is an adult-onset neurodegenerative disease caused by an
unstable, expanded CAG repeat in exon 1 of the huntingtin protein. While age of onset is
directly correlated with the length of the CAG expansion, there is significant variation
between individuals with a given CAG repeat which has been shown to be highly
heritable (Djousse et al., 2003; Wexler et al., 2004). There is thus great interest in
identifying genetic factors that are associated with this residual age of onset. We
investigate several genes with proteins that have known involvement with iron
homeostasis to test the hypothesis that iron regulation may influence age of onset of HD
in a large cohort of kindred in Venezuela. We enriched our assay specifically to study
the HFE gene on chromosome 6p21.3, where we found evidence for association with this
region in a male-specific model. We identified two major candidate genes for association
in this region and show that a single haplotype captures alleles that lead to later age of
onset of the disease.
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INTRODUCTION
Huntington's disease (HD) is a devastating adult-onset neurodegenerative
disorder characterized by choreiform movements, emotional disturbances, and cognitive
decline. Symptoms typically appear in mid-adulthood, with neurodegeneration that is
progressive and most pronounced in the striatum and cortex. An autosomal dominant
disease, HD is caused by the expansion of an unstable polyglutamine repeat in exon 1 of
the huntingtin gene on chromosome 4pl 6.3 (HDCRG, 1993). While unaffected
individuals have less than 26 repeats, incomplete penetrance results from 36-39 repeats,
and penetrance of the disease results from greater than 40 repeats (Myers, 2004). HD
also exhibits the phenomenon of genetic anticipation, in which a greater number of
repeats results in a more severe phenotype and earlier age of onset (Bates et al., 2002).
HD has been well characterized in a large Venezuelan cohort comprised of
individuals affected by HD and their unaffected family members. This well-studied
cohort spans 10 generations and includes 83 kindreds, most of whom are from the Lake
Maracaibo region of Zulia state (Wexler et al., 2004). These kindreds were instrumental
in the isolation of the HD gene and the characterization of the causative mutation
(HDCRG, 1993). Samples and extensive pedigree information have been collected
alongside data from neurological, neuropsychological, and cognitive examinations
performed almost yearly. Age of onset of HD is determined by motor assessment, either
prospectively by examination or retrospectively by oral history or by assessment of
current motor function severity.
Age of onset in HD is variable, and CAG repeat length accounts for
approximately 70% of this variation (Li et al., 2003). At any given repeat length,
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however, there is a considerable range of age of onset. This variability has been shown to
be strongly heritable both in a large North American cohort as well as in the Venezuela
cohort (Djousse et al., 2003; Wexler et al., 2004). Other genetic modifiers are thus
thought to affect age of onset of this disease.
It is thus of great interest to find genetic candidates that modify age of onset.
Two complementary genetic approaches are underway to address this issue. First,
genome-wide linkage scans use markers across the genome to narrow down candidate
regions of chromosomes without a priori hypotheses regarding gene product
functionality. In a large North American cohort, evidence for with residual age of onset
was reported to map to three regions of the genome: 4pl6, 6p21-23, and 6q24-26 (Li et
al., 2003). The second genetic approach is to test for association in candidate genes with
potential biological relevance to age of onset. One such category of candidates
associated with neurodegenerative diseases, especially those involving extrapyramidal
symptoms is genes involved with iron homeostasis (Moos and Morgan, 2004; Thompson
et al., 2001).
Higher concentrations of iron in the brain are associated with regions involved
with motor function, and iron in these regions increases with advancing age (Zecca et al.,
2004). Neurodegenerative diseases such as Parkinson's disease (PD) and Alzheimer's
disease (AD) have been associated with iron misregulation and toxicity. The association
of these diseases with HFE has thus been an area of increasing investigation (Dekker et
al., 2003; Zecca et al., 2004). In AD, for example, some studies report increased
oxidative stress and an earlier age of onset associated with HFE mutations although this
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association is still being investigated (Berlin et al., 2004; Candore et al., 2003; Pulliam et
al., 2003).
Additionally, disruptions in genes important for iron metabolism have been
associated with motor symptoms and neuronal phenotypes. For example, a mutation in
the ferritin light chain gene, which codes for a polypeptide subunit of the iron storage
protein ferritin, has recently been characterized and associated with a dominant, adult-
onset movement disorder known as neuroferritinopathy that affects the basal ganglia
(Curtis et al., 2001). Other evidence that suggests a possible connection between iron
metabolism and motor phenotypes is a knockout mouse model of the IRP-2 gene, whose
protein product regulates the expression of iron homeostasis genes. In one model, the
IRP-2 knockout mouse has a neurodegenerative movement disorder characterized by
bradykinesia, ataxia, and tremors (LaVaute et al., 2001). This movement disorder,
however, was not seen in a different IRP-2 knockout model, and therefore needs further
investigation (Galy et al., 2005).
Iron homeostasis has also been linked to HD pathogenesis. In vivo MRI analysis
of HD patients confirms postmortem studies showing increased iron deposition in HD
brains. In these studies, increased ferritin iron has been shown in the basal ganglia of
patients with HD and detected as early as 9 months from symptom onset (Bartzokis et al.,
1999). Recently, the iron and copper chelator clioquinol, has also been shown to be
effective in an in vitro assay as well as in a mouse model of HD (Nguyen et al., 2005). A
previous study in ES cells also suggested that iron depletion can lead to huntingtin
upregulation (Hilditch-Maguire et al., 2000).
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In order to investigate the potential effects of iron homeostasis on age of onset in
HD, we tested key variants in five genes involved in this process: transferrin, IRP-2,
ferritin light polypeptide, ferritin heavy polypeptide, and HFE. We focused specifically
on the HFE gene locus on chromosome 6p21.3, where a robust peak was reported in the
North American genome-wide linkage scan for HD residual age of onset.
MATERIALS AND METHODS
DNA Samples. Samples were obtained from 755 individuals from Venezuela who are
part of a large cohort of HD kindreds from the Lake Maracaibo area in Zulia State
(Wexler et al., 2004). DNA was previously isolated by phenol chloroform extraction or
with an anion exchange column (Qiagen), from lymphoblast cell lines that were
originally prepared from whole blood.
Genotyping. PCR amplification of a 500-1000 bp region surrounding each
polymorphism was performed in 96-well format using a thermocycler with a final
reaction volume of 12-50 A. PCR reactions were then denatured and spotted onto
Hybond N+ membranes (two identical membranes per PCR plate). Allelic discrimination
was performed by using allele-specific oligo (ASO) hybridizations. Each membrane was
then probed uising an allele-specific oligo labeled with y33P. Membranes were hybridized
for 1.5 hr-overnight, washed, and exposed to phosphor screens for subsequent
visualization. Images were acquired using a Storm Phosphoimager ® (GE) after 24 hours
of exposure and analyzed visually or with ImageQuant ® software (GE).
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Determination of residual age of onset. Age of onset for each sample was determined
previously (Wexler, 2004) by prospective and retrospective examination. Age of onset
(referring specifically to the onset of motor symptoms), was determined using a
combination of neurological tests either directly by examination or inferred from
symptom severity or from patient history. Residual age of onset was also calculated
previously (Wexler, 2004). Briefly, age of onset was modeled against the individual's
longer repeat number using linear regression. The curvilinear relationship was fitted
using the log transform age of onset. The predicted log transform age of onset was
subtracted from the log transform of the observed age of onset to determine residual age
of onset.
Statistical tests. Initial statistical analyses on all genotype data were performed by J.
Gayan (Wellcome Trust Centre for Human Genetics, Oxford, UK) using 1290
informative subjects from the larger pedigree arranged into 45 family groups. 17 families
had only a single member, while the remaining 28 had between 4-892 individuals.
Association for total age of onset and residual age of onset were examined using a Total
Association test, and an Orthogonal test as described in Abecassis et. al (2000a and b).
Parent of origin tests were also performed. Significant results were given by a p<0.05,
and trends were reported for p<0.1. Results from the tests above formed the basis of the
analysis presented in this work. Highly concordant results were obtained using both
analyses.
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The statistical analyses presented in this work were performed as follows:
Deviations from expected Hardy-Weinberg frequencies were calculated using the Chi-
square test and a Yate's correction with one degree of freedom. In order to compare each
pair of residual means, the equality of each pair of variances was assumed and the two-
sample t test for independent samples with equal variances was used to compute p values
(two-tailed test). Degrees of freedom for each pair of residual means was estimated by:
(s,2/n1+s22 /n 2 )/((s 2/nl) 2/(nl - 1)+(s22 /n 2)2 /(n2- 1)), where s represents the sample variances
and n represents the number of individuals in each group.
RESULTS
Genotyping of major polymorphisms in transferrin and IRP2 genes
We genotyped 6 polymorphisms in the transferrin gene and 2 polymorphisms in
the IRP-2 gene, all of which are known to lead to nonsynonymous amino acid changes in
the resulting proteins. These polymorphisms and their chromosomal locations are
presented in Table la. Four of these SNPs, (G142S, W37C, and T645P in transferrin;
and F272L in IRP2), were not polymorphic within our population. The other four SNPs
(G277S, 448V, and P589S in transferrin; and A852A in IRP2) were analyzed further for
association. Allele frequencies in our population are shown in Table lb. Only Tf4
(I448V) deviated significantly from Hardy-Weinberg equilibrium. Genotyping was
performed in 755 individuals, including those with expanded CAG repeats and familial
controls. Association analyses for age of onset was performed on 425 individuals from
the CAG expanded group (Orthogonal and X test: Wellcome Trust, Oxford), whose
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disease had become clinically significant (i.e. they had a documented age at onset). Tf5
showed a trend toward association with p=0.05, however, this fell above our cut-off of
p<0.0 5 .
Sequencing of ferritin gene loci
In order to search for candidate polymorphisms specifically relevant to our
population, we sequenced regions of the ferritin light polypeptide (FTL) and ferritin
heavy polypeptide 1 (FTH1) genes. We sequenced 2.2 kb of the FTL gene on
chromosome 9q13 (chrl9: 54160006-54161850, including exons 1, 2, 3 and partial exon
4 sequence) and 1.2 kb of the FTH1 gene on chromosome 1 lq12 (chrl 1: 61488603-
61489721, including part of exon 1 and all of exons 2 and 3). For this analysis, we
sequenced samples from 16 individuals, whose residual ages of onset ranged from 17.11
years earlier to 22.86 years later than expected based on CAG repeat length. These
individuals are listed in Table 2. Samples were selected from different familial branches
of the larger pedigree as shown. We found only a single polymorphism among these
samples (rs 8108882) that does not result in an amino acid change (L55L). There was
some suggestion of association in the cohort sequenced; however, further analysis in a
larger cohort is needed to confirm these results.
High density SNP analysis of HFE gene and surrounding 43.6 kb
We then focused on a high density SNP analysis of the HFE locus, using 29
markers spanning 43.6 kb centered on the HFE gene. These SNPs are presented in Table
3 and shown schematically in Figure 1. Included among these SNPs are four
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polymorphisms that result in nonsynonymous changes in the resulting amino acid. These
SNPs are listed with the amino acid changes shown next to the SNP name. Three of
these SNPs are found in HFE: 532-1(H63D), 532b-3(S65C), and 536(C282Y), while one
of these SNPs is found in histone 1Hlt: 565-2(Q178K). Initial statistical tests (performed
by J. Gayan, Wellcome Trust, Oxford) showed evidence for association among a
selection of these SNPs that was most robust in a male-specific model (Abecasis et al.,
2000a; Abecasis et al., 2000b). In order to examine this more closely, the mean residual
ages of onset in males was calculated for each genotype class for all 29 SNPs. Each
combination of two SNP alleles gave a total of three genotype classes: one homozygote
class for each SNP and a third heterozygote class. The means from these three classes
were compared in pairs. Thus, for a hypothetical diallelic SNP in which alleles A= 1 and
G=2, for example, mean residual age of onset for the three genotype classes of 11, 22,
and 12 (AA, GG, and AG respectively) were compared in the groupings: 11 vs. 22, 11 vs.
12, and 22 vs. 12. In all cases except where indicated, the SNP allele corresponding to
the ancestral allele as inferred from pan troglodyte (chimp) sequence was designated the
reference allele, 1. The remaining alternate allele was designated 2. The mean residual
ages of onset as well as these comparisons are shown in Table 4. The statistical
significance of the difference between each mean was determined by calculating a p
value using a two-sample t test (two-tailed). A p value of < 0.05 was considered
significant (highlighted in yellow in Table 4), while a p value of <0.1 was considered
suggestive of association (highlighted in orange in Table 4). A total of seven SNPs
showed significant (p<0.05) differences in mean age of onset between genotype classes.
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The location of these SNPs in relation to the HFE locus are shown schematically in
Figure 1.
Six SNP markers showing the strongest association (largest differences between
residual means among genotype classes with smallest p values) are shown in Table 5.
Also noted in this Table are any deviations from Hardy-Weinberg equilibrium among
these SNPs in the population. To demonstrate that the association present between age of
onset and these SNP markers is most robust in a male-specific manner, Table 5 also
presents the differences in mean residual ages of onset by genotype class for the same
SNPs in both sexes combined (males + females, top panel), as well as for females only
(bottom panel) for comparison. As shown, some statistical significance was noted when
males and females were combined. However, no significant differences in mean age of
onset was noted for any genotype class combinations in the female group. Therefore, the
associations seen in both males and females combined, therefore, appear to derive from
the male-only associations, where the most robust effect is seen.
To demonstrate graphically the effect that different SNP allele combinations can
have on age of onset, the mean residual ages of onset by genotype class are shown for
SNPs 558, 565, and 575 in Figures 2 a,b, and c, respectively. Error bars represent
standard deviations. SNP 565 demonstrated the largest difference in age of onset, with
homozygotes of one allele (GG) developing onset of the disease 7.97 years later
(p=O.009) when compared with homozygotes of the other allele (AA).
We reasoned that the SNPs showing significant association with age of onset in
HD most likely had alleles that could be found in linkage disequilibrium with each other.
Therefore, we wanted to determine if a "protective" haplotype could be found within the
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population. We resolved haplotypes using pedigree information from 102 chromosomes
within the cohort. A summary showing a representative illustration of each haplotype
found in the population is shown in Figure 3. Using the seven SNPs that showed the
highest association with age of onset (indicated by arrows in Figure 3), we found a single
haplotype carrying "favorable" alleles at each of these SNPs (the presence of each
favorable allele resulted in a later age of onset when the SNP was tested individually for
association). This haplotype was found in 10 of the 204 haplotypes we examined and is
shown in Figure 3. Conversely, a haplotype with "unfavorable" alleles at all seven most
associated SNPs was also found in 41 of the 204 haplotypes we examined.
One of the SNPs that demonstrated significant association with age of onset with
HD is SNP565-2(Q178K). The effect of this SNP on age of onset is shown graphically in
Figure 4. The reference SNP allele corresponds to the first position of a glutamine
codon. The alternate allele changes this glutamine (uncharged) to a lysine (basic) in the
resulting histone Hilt protein (Figure 5a). The reference allele sequence is conserved in
chimp, mouse, rat, dog, chicken, and zebrafish, as shown in Figure 5b. In addition,
chimp, mouse, and rat sequences all have a corresponding glutamine at that position.
DISCUSSION
We present here evidence for association between a 43.6 kb region on 6p21.3 and
residual age of onset in Huntington's disease in a male-specific manner. The statistical
analyses presented in this report have been corroborated by further rigorous testing.
First, regression analysis was used to replace the comparison of each allele class (as
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shown in this report), in order to reduce the effects of multiple testing. Second, to
account for the fact that many affected individuals in our cohort are related by birth, a
modified TDT test (Abecasis et al., 2000b) was performed to control for possible
stratification bias. These tests (performed by J. Gayan, Wellcome Trust, Oxford) placed
more stringent requirements for association but nevertheless gave highly concordant
results with those shown in this report, thus validating our findings of a male-specific
association with HD age on onset in this region.
A previous study using a genome-wide linkage scan in a large North American
HD cohort (Myers) reported a peak on 6p21-23 suggesting linkage to residual age of
onset this region. We found multiple markers within 43.6 kb that showed significant
association (p<0.05) with residual age of onset. Seven markers with the most significant
association had alleles that could be grouped together as "favorable" or "unfavorable"
depending on whether age of onset occurred later or earlier than expected, respectively,
according to AG repeat length. All seven "favorable" alleles could be found together
on a single haplotype in the population, as could all seven unfavorable alleles.
Here we present two candidate genes for association in this region. The first
candidate gene is the HFE gene. Six of the seven most associated SNPs flank this gene,
while a seventh SNP, SNP 532-2, falls within the gene between exons 2 and 3. HFE is a
biological candidate for modification of HD age of onset due to its involvement with iron
homeostasis. Iron increases in the brain with advancing age in humans, and it has been
suggested that this may be correlated with the adult-onset nature of HD. Additionally,
increased iron deposition is seen in regions of the brain in HD patients that are most
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affected by the disease (Bartzokis et al., 1999). We detect an association which is most
robust in males.
The most obvious candidate variants in the HFE gene are previously identified
mutations known to disrupt normal function of the HFE protein in iron homeostasis. We
tested three of these mutations for association: C282Y(SNP 536), H63D(SNP 532-1), and
S65C(SNP 532b-3). Interestingly, the haplotype containing the "favorable" alleles of the
seven associated markers in this region and thus conferring a "protective" haplotype, also
contains the alternate allele for SNP 532-1, which corresponds to the H63D mutation.
H63D was also tested for association directly, but only five homozygotes for the mutation
were found in our cohort. This small number likely led to a lack of power to achieve
statistical significance. H63D thus remains a viable candidate since the other
significantly favorable alleles are in linkage disequilibrium with this marker. A case-
control study specifically focused on selecting HD patients with and without this
mutation will directly address this issue. The male-specific nature of our association is
interesting in light of reports that males with HFE mutations present with more severe
iron overload phenotypes when compared with premenopausal women (Deugnier et al.,
2002). It would be of interest to investigate how systemic iron overload and brain iron
overload are correlated, or possibly inversely correlated.
The second candidate gene we identified is histone Hlt, found downstream from
HFE in the locus we examined. Our data reveals that SNP 565-2(Q178K), has alleles
which show significant association with age of onset. Specifically, we found that a single
T allele, which changes the resulting amino acid from a glutamine to a lysine, results in a
2.37 year earlier age of onset (p=0.004) in heterozygotes with the genotype GT.
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Interestingly, this nucleotide sequence is conserved in other organisms (chimp, mouse,
rat, dog, chicken, and zebrafish), and the glutamine at that position also appears in the
chimp, mouse, and rat proteins. Homozygotes of the T allele also develop an earlier age
of onset, although this did not reach statistical significance in our cohort likely due to the
fact that the small number (n=10) of homozygotes in our population. The alternate allele
(T) at this SNP, changes an uncharged amino acid (Q) to an acidic residue (K). The
significantly earlier age of onset observed in heterozygotes when compared to
homozygotes of the G allele, suggests a dominant-negative mechanism resulting from
this amino acid change.
We have demonstrated a male-specific association with residual age of onset in
HD within a 43.6 kb region of 6p21.3 using a large cohort of HD kindreds from
Venezuela. We present two candidate genes, HFE and Hit in this region, that singly or
together may explain this association. Multiple markers in the region on defined
haplotypes demonstrating significant association argue against a statistical artifact and
instead suggest a real association that should be confirmed in other studies. Additional
testing of these candidates in other populations as well as further genetic and biological
tests should help to explain the physiological impact of these candidate genes on age of
onset in HD.
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Table 1: Summary of SNPs in transferrin and IRP2 genes tested for association with
residual age of onset.
a: SNPs selected for analysis.
SNPs producing an amino acid change in the resulting protein were chosen for analysis.
Only four of these SNPs were polymorphic in the population we examined. The name of
each SNP used in our study is shown alongside the reference SNP ID (rs#) assigned by
the NCBI database.
b: Genotypes of polymorphic SNPs selected for analysis.
The number of genotypes for each allele class (11, 12, or 22) in polymorphic SNPs
selected for association analysis in the transferrin and IRP2 genes are shown. Results
from a Chi square test for deviations from Hardy-Weinberg equilibrium (with and
without the Yates correction) is shown to the right. None of these SNPs showed
significant association with age of onset in the population (not shown).
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Table 2: Summary of samples chosen for sequencing in ferritin genes.
Individuals were chosen for sequencing sequencing 2.2 kb on the ferritin light
polypeptide (FTL) and ferritin heavy polypeptide 1 (FTH1) gene. These individuals were
chosen from the larger cohort for their residual ages of onset ranging from 17.11 years
earlier to 22.86 years later than expected based on CAG repeat length. Each individual is
represented by a code with characteristics as shown.
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Table 3: Summary of SNP markers on 6p21.3 used in analysis.
The SNP markers used in this analysis is shown. The name of each SNP used in our
study is shown alongside the reference SNP ID (rs#) assigned by the NCBI database. The
allele corresponding to the ancestral or chimp sequence, was designated as the reference
allele (1) in all cases except where indicated (SNP 501 and SNP 512). The alleles shown
correspond to the (+) strand on chromosome 6p21.3.
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Figure 1: Schematic representation of SNPs in a locus on 6p21.3 used in analysis
and significantly associated.
29 SNP markers (see also Table 3) spanning a 43.6 kb region on 6p21.3 as shown were
used in this analysis. Each SNP marker is represented by an open circle and shown from
left to right. The distribution of these SNPs in relation to the genes present in this locus
are shown. In addition to the HFE gene, this region also includes two histone genes:
1H4C and 1H I t, respectively, downstream from HFE as shown. SNPs showing
significant association with residual age of onset in HD are labeled with a filled arrow.
The SNPs used in this analysis that lead to non-synonymous amino acid changes in the
corresponding protein are shown above each relevant SNP (*).
Table 4: Differences between mean residual age of onset in males by genotype class
for 29 SNP markers analyzed.
For each SNP, the number (n) of individuals in each genotype class (11, 12, or 22) is
shown (left panel). The corresponding mean residual age of onset and standard deviation
is shown beneath each genotype class. The differences between these residual means
(22-11, 11-12, 22-12), is shown in the right panel with a p value computed using a t-
sample t test (two-tailed). p values significant for association (p<O.05) are highlighted in
yellow. p values suggestive of association (p<O. 1) are highlighted in orange.
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Table 5: Differences between mean residual age of onset by genotype class shown
for six most significantly associated SNPs for each gender.
The six SNP markers showing the largest differences in age of onset with the smallest p
values form Table 4 are shown here. The same analysis was performed in males and
females combined (ALL, top panel), Males only (middle panel), and Females only
(bottom panel). p values significant for association (p<0.05) are highlighted in yellow. p
values suggestive of association (p<O. 1) are highlighted in orange. No association was
found among these SNPs in females only, suggesting the association seen in males and
females combined derived from robust male-specific associations.
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4.16 0.0172 .Q.37 0.5428 3.78 0.0303
-0.95 0.4068 1.35 0.0263 0.40 0.7188
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Table 5
.deviates from HWE
22-11 p 11-12 p 22-12 p
2.49 0.0257 -2.21 0.0091 0.28 0.8138
3.36 0.0147 -0.10 0.9078 3.26 0.0250
-3.31 0.0415 2.87 0.0007 -0.44 0.7529
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Genotypes Total n Difference: betWeen residual means by genotype
11 12 22
MALES ONLY
SNPname
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sm 4.90 5.73 6.01
557 n 60 118 22 200
Mean -0.04 0.06 3.33
sm 4.72 5.85 6.35
558 n 71 119 17 207
Mean 2.28 -059 -1.03
SID 5.87 5.33 5.06
565 n 134 67 6 207
Mean 0.07 0.46 8.04
SID 5.10 5.84 9.00
565-2 n 104 90 10 204
Mean 158 -0.79 -0.52
SID 5.48 5.73 3.66
575 n 71 120 17 208
Mean 2.28 -0.56 -1.03
SID 5.87 5.34 5.06
22-11 P 11-12 P 22-12 p
0.77 0.5417 -0.1] 0.9149 0.66 0.5737
0.10 0.9417 0.03 0.9761 0.13 0.9185
-0.61 0.6565 0.49 0.5899 -0.12 0.9237
1.80 0.4274 -0.35 0.6990 1.45 0.4861
-0.32 0.8333 0.42 0.6380 0.10 0.9461
-0.61 0.6565 057 0.5355 -0.04 0.9762
Genotypes Total n Difference betWeen residualmeans by genotype
II 12 22
FEMALES ONLY
SNPname
532-2 n 74 112 43 229
Mean 0.64 0.75 1.41
SID 6.64 6.58 6.29
557 n 86 108 32 226
Mean 0.93 0.91 1.04
SID 6.98 6.45 6.03
558 n 92 105 36 233
Mean 1.14 0.64 0.53
SID 6.92 5.95 7.05
565 n 146 77 10 233
Mean 0.49 0.84 2.29
SID 6.73 6.02 5.65
565-2 n 107 101 26 234
Mean 0.97 0.55 0.65
SID 6.77 6.04 7.80
575 n 92 108 36 236
Mean 1.14 0.56 0.53
SID 6.92 6.16 7.05
Figure 2(a-c): Graphical representation of mean residual ages of onset in males
sorted by genotype class for SNP 558 (a), SNP 565 (b), and SNP 575 (c).
The mean residual age of onset for each genotype class (11, 12, or 22) is shown by a
colored circle. Error bars represent standard deviations. The number (n) of individuals in
each class is shown to the right. The number of years between each mean is shown
below (brackets) with p values derived from a two-sample t test (see also Table 5).
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Figure 3: Representative haplotypes from the population showing haplotypes
containing SNP alleles associated with a later or earlier age of onset.
204 haplotypes were resolved from a selection of 102 chromosomes in the population. A
representation of each type of haplotype is shown. SNPs showing significant association
with male-specific age of onset are highlighted (arrows). The "favorable" alleles for each
of these SNPs producing a later age of onset in males can be found together on a single
haplotype as shown found in 10 of the 204 haplotypes studied. The "unfavorable" alleles
leading to an earlier age of onset in males is also found together on a single haplotype as
shown and was observed in 41 of the 204 haplotypes examined.
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Figure 4: Graphical representation of mean residual ages of onset for SNP 565-
2(Q178K).
The mean residual age of onset for each genotype class (11, 12, or 22) is shown by a
colored circle. Error bars represent standard deviations. The number (n) of individuals in
each class is shown to the right. The number of years between each mean is shown
below (brackets) with p values derived from a two-sample t test (see also Table 5).
r:J)
~-~
~
c::.-......,
~
r:J)c:: v
0 000.-10\.-1II II II
~ c: c: c:
0 •••
r:J)
~
OJ)
<-~::s
"\j.-r:J)
~
~a
~
;:E
~
0
c::
0
r:J).-
~
A
S
0u
..-,
~
00
t:"-
~
0
'-'
N
I
lI")
\0
lI")
~z
r;/J
,-....
0'\
00
0
II
5
en
1-4
~
(l) ,-....~ \0
t- N
N 0
II
0..
'-'"
rJJ
~
,-.... (l)
v ~
0 0
0 -0 N
II
5
en
1-4
~
(l)
~
t-
~
N
r---------------r.- .. ~.~-...--- -----.------,--------- ..-,---.--.,.--.--.-.--- ..-- ..--~ uro._. ....._._ e_-"l-- ---
o
N
o .,.
Figure 5: A single nucleotide change at SNP 565-2 affects an amino acid which is
conserved in other species.
a: The SNP alleles at SNP 565-2 result in a non-synonymous amino acid change.
A single nucleotide change at SNP 565-2 to the alternate allele (A) changes a glutamine
to a lysine in the resulting Hlt protein. Codon 179 is shown in green, with the position of
SNP 565-2 highlighted in red. Note that the nucleotides shown correspond to the (-)
strand of chromosome 6p21.3
b: The reference allele of SNP 565-2 is conserved in other organisms.
The reference allele of SNP 565-2 (C) is shown conserved in chimp, mouse, rat, dog,
chicken, and zebrafish sequence. Note that the sequence in chimp, mouse, and rat all
result in a conserved glutamine codon at that site.
or
or
or
or
or
1+
Chapter 4
Conclusions and Prospects for future work
129
Haplotype analysis and recombination events in the HFE locus
Local sites of crossover recombination in HFE
We provide evidence for a local recombination hotspot in the HFE gene,
occurring in a cluster with the most frequent crossover activity evident between exons 1
and 2 in the FIFE gene. While not an active site for crossing over relative to a genome-
wide comparison of hotspots, we demonstrate that historical crossovers at these sites can
explain the blocks of haplotype observed in this region. As expected, this site for
crossing over forms the boundaries of haplotype blocks.
It is interesting to note that two of the mutations that can lead to
hemochromatosis, H63D and S65C (represented by SNP 532-1(H63D) and SNP 532b-
3(S65C) in our study), are located in the immediate vicinity of the hotspot we identified.
Another non-CpG mutation, Q 27H that has been reported in South African patients with
iron overload (de Villiers et al., 1999), is also located within 1 kb of this region. At least
one report has suggested increased nucleotide diversity at RHS (Jeffreys et al., 2000).
Double strand breaks initiate recombination at a hotspot, so it is interesting to consider
the possibility that these breaks and subsequent repair can promote a greater number of
mutations in that region.
Gene conversion events in the HFE locus
We provide evidence for gene conversion events that are not limited to
recombination hotspots using haplotype analysis in the human HFE locus. To understand
the significance of this mechanism in influencing haplotype structure, we measured the
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frequency with which these events occurred in a single generation using progeny of
mouse backcrosses derived from genetically divergent strains. Our results provide a
direct demonstration of gene conversion events resulting from mammalian female
meioses. We detected two confirmed conversion events in 23,753 genotypes which gives
a frequency even higher than our estimated gene conversion frequency of approximately
1 in 106 per site per generation derived from human haplotype analysis. These events
were not limited to a hotspot for crossing over.
Our observation that gene conversion events are not limited to recombination
hotspots has important consequences for our general understanding of the mechanism of
gene conversion. Crossovers and gene conversions have long been thought to result from
the alternate resolution of a single late intermediate (Szostak et al., 1983). Such a model
predicts that these events occur at shared hotspots. In yeast, however, gene conversions
can arise with crossover events, or can arise independent of crossovers (at sites of
"noncrossovers"). A recent model proposes that these two pathways diverge shortly after
a common initiating double strand break (Borner et al., 2004). By extrapolation, this
supports the possibility that gene conversion events are not limited to locations where
crossovers take place, i.e. RHS. If this model is applicable to mammalian meiotic events,
then we could imagine punctate areas of the genome vulnerable to double strand breaks,
some of which could resolve either with gene conversion or crossover, while others
would consistently resolve with gene conversions only. This not only supports our
findings of gene conversions not limited to hotspots but is also consistent with studies
measuring the relative frequencies with which gene conversions occur in relation to
crossovers. One could imagine a more transient strand invasion that might be required
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for a gene conversion (modeled by several models in yeast including synthesis dependent
strand annealing) (Bishop and Zickler, 2004) rather than a more committed mechanism
required for crossover. This model would make gene conversion events more frequent
than crossover events. This is consistent with evidence that gene conversion: crossover
frequencies measured in mouse and human sperm at RHS are reported at rations of 4:1-
15:1 (Jeffreys and May, 2004). Our data also supports a high frequency of gene
conversion events.
In addition to contributing to our overall understanding of gene conversion events
in mammals, our data also carries important implications for the haplotype-based
approach to finding genes responsible for contributing to complex traits. Using
haplotype data in human chromosomes, we show that gene conversion events cause
short-range sequence changes that can occur within a haplotype block (i.e. not limited to
recombination hotspots at the borders of these haplotype blocks). These conversion
events cause punctate changes that will lead to the eventual establishment of new
haplotypes as these chromosomal segments are propagated in a population.
The frequency with which gene conversion events occur leads us to suggest that
gene conversion events can be an extremely useful tool as markers of specific groups of
chromosomes in the course of disease association studies. A popular approach suggested
by the HapMap project is to define a set of "tag SNPs" that when used in association
studies will capture most of the power of a complete set of common SNPs to identify the
sites of DNA sequence variation for genes contributing to human complex traits. "Tag
SNPs" are a selection of SNPs on each block that captures the information about common
SNPs that identify an entire block. The idea is to reduce the complexity of haplotype
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blocks and decrease the genotyping of redundant SNPs in the same block. These tag
SNPs are useful for identifying a haplotype block on which a particular mutation may lie.
However, this approach is effective only when the variant site leading to phenotypic
effect is similar in frequency to the haplotype tagging SNPs. If, on the other hand, as
some have speculated, the causal allele is less common than these tag SNPs (the causal
allele may have arisen in a more recent event, for example), then they could be missed by
such an approach. We propose that haplotypes created by gene conversion events will
occur with a frequency and distribution ideally suited for tracking sites of DNA variation
responsible for phenotypic effects in complex trait association studies in cases when these
alleles are less common in the population.
The occurrence of gene conversion events would lead to the subdivision of
haplotype blocks which we suggest can be used to subdivide haplotype classes allowing
significantly greater power to reveal association with a disease-causing allele than can be
obtained with a single set of haplotype-tagging SNPs.
Figure 1 illustrates this strategy schematically. A single haplotype block (shown
in red) is present on an ancestral chromosome (topmost). Descendants of this ancestral
chromosome will all carry the same haplotype block (red). On one of these, a mutation
(indicated by a star) will occur that contributes to a complex trait (disease). Descendants
receiving this disease-causing mutation will also receive the corresponding red haplotype
on which the mutation arose. A gene conversion (represented by a *) is also shown that
happens close in time to the disease-causing mutation that will be inherited by red
haplotypes also carrying the mutation. Tag SNPs would be represented by any marker on
the haplotype identifying it as "red". While the disease-causing allele is found only on
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red chromosomes, not all red chromosomes carry the disease allele. By only using tag
SNPs that are common to the red or "framework" haplotype, therefore, we are diluting
our sample and reducing our power to detect the disease-causing mutation. However,
sampling these tag SNPs along with the gene conversion directly, would allow us to
select only the subset of the red chromosomes that carry the disease-causing mutation as
well.
How could one most efficiently identify such haplotypes created by gene
conversion? In the context of a genome wide association study, the most likely way to
identify such haplotypes would be to include multiple sites within a haplotype block, with
varying allele frequencies, rather than relying upon a small but redundant set of
haplotype-tagging SNPs. In addition, candidate regions can be identified by functional
considerations or by initial genome-wide linkage or association studies. Haplotypes that
arise as a consequence of gene conversions that are associated with a disease-causing
variant sequence can emerge from the sequencing of these candidate regions in affected
individuals with disease phenotypes. As technology moves towards the relatively lower
cost sequencing of whole genomes, the potential for directly identifying high power
haplotypes created by gene conversion for association studies should be considered an
integral part of the analytical approach to the identification of disease causing genetic
variants.
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Association study: HD residual age of onset and the HFE region
We demonstrated evidence for association with residual age of onset in HD with a
43.6 kb region of 6p21.3 and have identified two major candidate genes in this region.
Seven SNPs that we tested show significant association that is most robust in a male-
specific context. Biological experiments will best address the physiological relevance of
the two genes in relation to HD pathogenesis.
The first candidate gene we identified is the HFE gene, whose protein product is
involved with iron homeostasis. A series of seven most significantly associated SNPs
found in the locus we tested flanked the HFE gene. In addition, the "favorable" alleles of
these seven SNPs could be found on a single haplotype in the population we examined.
This haplotype with alleles associated with a later age of onset of HD also contained the
H63D mutation of HFE. While the H63D mutation itself (tested as SNP 532-1) did not
show statistical significance with age of onset, only five homozygotes with this mutation
in the population decreased our power to detect an association considerably. The high
prevalence of H63D throughout the world has led to much speculation regarding a
potential protective role of this mutation. It is intriguing to consider that this mutation
may affect iron handling in the aging brain.
To begin to address the physiological issue of iron homeostasis and HD
pathogenesis, we are conducting a series of experiments using the R6/2 mouse model of
HD. We have nearly completed an investigation into the clinical usefulness of an
iron/copper chelator, clioquinol, a lipophilic molecule able to cross the blood brain
barrier and investigated for its clinical usefulness in other neurodegenerative diseases
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including Alzheimer's disease (in which a Phase II human clinical trial is currently in
progress) (Cherny et al., 2001; Finefrock et al., 2003) and Parkinson's disease (in which
clioquinol has been shown to mitigate the motor defects in an MPTP-induced Parkinson's
mouse model) (Kaur et al., 2003). Thus far, we have not seen significant effects on age
of onset in these animals (assessed by motor phenotypes), although a current report does
suggest that this drug may ameliorate R6/2 motor phenotypes (Nguyen et al., 2005).
Measurements of CAG repeat length in our animals should help to address the disparity
of these results. We are also approaching this question by investigating the effects of
crossing the R6/2 model to transgenic animals with alterations in genes involved with
iron homeostasis to assess whether these disruptions can affect age of onset of the HD
phenotype.
The second candidate gene we identified is the histone Hlt gene, a testis-specific
gene reported to be expressed during spermatogenesis (Drabent et al., 1991). A single
variant in this gene, Q 178K, corresponding to SNP 565-2, leads to an earlier age of onset
in individuals carrying this mutation. Based on the fact that the largest effect is seen in
heterozygotes carrying this mutation (rather than a gradient in which heterozygotes show
an intermediate phenotype), we suggest that the Q1 78K mutation leads to a dominant
negative effect on phenotype. To address how this mutation could lead to earlier age of
onset we considered several possibilities. The first possibility is that the Q 78K mutation
directly effects expansion of the CAG repeat in spermatocytes. This would corroborate
our findings of a male-specific association as well as reports of increased CAG expansion
occurring through paternal transmission seen both in human patients (Bates et al., 2002),
and in HD mouse models (Mangiarini et al., 1997). Our tests for association, however,
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looked specifically at male patients rather than their progeny. If this were the reason for
the association we detected, then it might be due to the fact that children of male parents
carrying the mutation might also be expected to inherit the mutation. A more direct test
to see if this mutation leads to greater CAG expansion in the next generation would be to
compare the progeny of males with the Q 178K mutation with the progeny of males
without the mutation. We would expect, in this case, to see a greater mean CAG repeat
length in children of males carrying the mutation. We performed this statistical test on
our cohort, and did not observe a significant difference in mean CAG length of children
of males carrying the Qi178K mutation. Our sample size was considerably reduced,
however, and likely too small to detect an effect with adequate statistical significance.
Other reports, however, such as studies in one HD mouse model suggest that sex-
dependent factors in the embryo itself may also result in more CAG expansion in male
mice vs. female mice (Kovtun et al., 2000). This would be consistent with our male-
specific association, although challenging to explain if the mutation is only expressed in
the testis during spermatogenesis. In addition, general transcriptional misregulation has
often been associated with HD pathogenesis and for this reason histone deacetylase
(HDAC) inhibitors have been the focus of several preclinical investigations in HD
(Hockly et al., 2003). Again, for a mutation in histone Hlt to lead to general
transcriptional misregulation, it will be necessary to assess whether its expression is in
fact limited to the testis or not. To address this issue, we are examining expression of
H 1 t specifically focusing on the brain by Northern analysis. While previous reports
suggest expression largely restricted to the testis, microarray analyses suggest the
potential for expression in other tissues (http://symatlas.gnflorg/SynAtlas/, Probe set id:
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207982_at). Brain expression would offer the possibility that the histone gene in some
way influences CAG expansion in males in the somatic cells which are most affected by
HD (albeit by a mechanism still poorly understood), leading to earlier age of onset as
seen with the histone Hit variant Q178K. HD pathogenesis is still an area under intense
investigation. Understanding the nature of the impact of HFE and/or histone Hlt on age
of onset will shed light on disease progression and provide new options for therapeutic
interventions to delay age of onset of this devastating disease.
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Figure 1: Schematic to illustrate a strategy for subdividing haplotypes using gene
conversion events.
A haplotype block (shown in red) that lies on an ancestral chromosome is illustrated. If a
mutation (star) occurs on a descendent of this chromosome on the red haplotype, all
chromosomes with the disease allele will also have a portion of the red haplotype.
Sampling a population with tag SNPs alone will identify all "red" haplotypes, only some
of which contain the disease-causing allele. Gene conversion events that happen close in
time to the mutation (*) could be useful tools for the subdivision of haplotypes.
Sampling for the red haplotype and the gene conversion will enrich a sample for
mutation-containing haplotypes.
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